12e8:L (ASP1) to (LEU106) 2E8 FAB FRAGMENT | IMMUNOGLOBULIN
12e8:M (ASP1) to (LEU106) 2E8 FAB FRAGMENT | IMMUNOGLOBULIN
1ndg:A (ILE2) to (ILE106) CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTIBODY HYHEL-8 COMPLEXED WITH ITS ANTIGEN LYSOZYME | ANTIBODY; LYSOZYME; MUTANT; HYHEL-8, IMMUNE SYSTEM/HYDROLASE COMPLEX
1ndm:A (ILE2) to (ILE106) CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTIBODY HYHEL-26 COMPLEXED WITH LYSOZYME | ANTIBODY; LYSOZYME; MUTANT; HYHEL-26, IMMUNE SYSTEM/HYDROLASE COMPLEX
3rp1:B (ARG28) to (LEU119) CRYSTAL STRUCTURE OF HUMAN LAIR-1 IN C2 SPACE GROUP | STRUCTURAL GENOMICS, COLLAGEN RECEPTOR, NEW YORK STRUCTURAL GENOMICS RESEARCH CONSORTIUM, NYSGRC, PSI-BIOLOGY, IG-LIKE, IMMUNE SYSTEM, COLLAGEN-BINDING
3rrq:A (PRO34) to (VAL144) CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF HUMAN PD-1 | PD-1; PROGRAMMED DEATH-1, COSTIMULATORY, IMMUNE SYSTEM
1ad9:L (ASP1) to (VAL106) IGG-FAB FRAGMENT OF ENGINEERED HUMAN MONOCLONAL ANTIBODY CTM01 | IMMUNOGLOBULIN, FAB FRAGMENT
3efd:L (ILE2) to (ILE106) THE CRYSTAL STRUCTURE OF THE CYTOPLASMIC DOMAIN OF KCSA | HELIX BUNDLE, C-TERMINUS, IMMUNE SYSTEM
3rvu:C (VAL3) to (MET106) STRUCTURE OF 4C1 FAB IN C2221 SPACE GROUP | IGG, ANTIBODY, DER F 1, DER P 1, IMMUNE SYSTEM
3rvx:C (ILE2) to (MET106) CRYSTAL STRUCTURE OF DER P 1 COMPLEXED WITH FAB 4C1 | DER P 1, ALLERGEN-ANTIBODY COMPLEX, HYDROLASE-IMMUNE SYSTEM COMPLEX
2oqj:A (VAL2) to (ILE106) CRYSTAL STRUCTURE ANALYSIS OF FAB 2G12 IN COMPLEX WITH PEPTIDE 2G12.1 | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
2orb:L (VAL3) to (ILE106) THE STRUCTURE OF THE ANTI-C-MYC ANTIBODY 9E10 FAB FRAGMENT | ANTIGEN-ANTIBODY COMPLEX, ANTIGEN RECOGNITION, LONG CDR H3, IMMUNE SYSTEM
2orb:M (VAL3) to (ILE106) THE STRUCTURE OF THE ANTI-C-MYC ANTIBODY 9E10 FAB FRAGMENT | ANTIGEN-ANTIBODY COMPLEX, ANTIGEN RECOGNITION, LONG CDR H3, IMMUNE SYSTEM
2or9:M (VAL3) to (ILE106) THE STRUCTURE OF THE ANTI-C-MYC ANTIBODY 9E10 FAB FRAGMENT/EPITOPE PEPTIDE COMPLEX REVEALS A NOVEL BINDING MODE DOMINATED BY THE HEAVY CHAIN HYPERVARIABLE LOOPS | ANTIGEN-ANTIBODY COMPLEX, ANTIGEN RECOGNITION, MYC-TAG, LONG CDR H3, IMMUNE SYSTEM
4hcr:N (ILE2) to (ILE111) CRYSTAL STRUCTURE OF HUMAN MADCAM-1 D1D2 COMPLEXED WITH FAB PF-547659 | IMMUNOGLOBULIN SUPERFAMILY, ROLLING AND FIRM ADHESION, INTEGRIN ALPHA4BETA7, IMMUNE SYSTEM
4hha:A (VAL3) to (ILE106) ANTI-HUMAN CYTOMEGALOVIRUS (HCMV) FAB KE5 WITH EPITOPE PEPTIDE AD-2S1 | FAB FRAGMENT, ANTIBODY, IMMUNE SYSTEM
4hie:A (GLY2) to (ILE106) ANTI-STREPTOCOCCUS PNEUMONIAE 23F FAB 023.102 | IMMUNOGLOBIN, ANTIBODY, STREPTOCOCCUS PNEUMONIAE 23F, IMMUNE SYSTEM
4hih:A (GLY2) to (ILE106) ANTI-STREPTOCOCCUS PNEUMONIAE 23F FAB 023.102 WITH BOUND RHAMNOSE. | IMMUNOGLOBIN, ANTIBODY, STREPTOCOCCUS PNEUMONIAE 23F, IMMUNE SYSTEM
4hih:C (GLY2) to (ILE106) ANTI-STREPTOCOCCUS PNEUMONIAE 23F FAB 023.102 WITH BOUND RHAMNOSE. | IMMUNOGLOBIN, ANTIBODY, STREPTOCOCCUS PNEUMONIAE 23F, IMMUNE SYSTEM
4hii:A (GLY2) to (ILE106) ANTI-STREPTOCOCCUS PNEUMONIAE 23F FAB 023.102 WITH BOUND RHAMNOSE- GALACTOSE | IMMUNOGLOBIN, ANTIBODY, STREPTOCOCCUS PNEUMONIAE 23F, IMMUNE SYSTEM
4hii:C (GLY2) to (ILE106) ANTI-STREPTOCOCCUS PNEUMONIAE 23F FAB 023.102 WITH BOUND RHAMNOSE- GALACTOSE | IMMUNOGLOBIN, ANTIBODY, STREPTOCOCCUS PNEUMONIAE 23F, IMMUNE SYSTEM
4hij:C (GLY2) to (ILE106) ANTI-STREPTOCOCCUS PNEUMONIAE 23F FAB 023.102 WITH BOUND L-RHAMNOSE- (1-2)-ALPHA-D-GALACTOSE-(3-O)-PHOSPHATE-2-GLYCEROL | IMMUNOGLOBIN, ANTIBODY, STREPTOCOCCUS PNEUMONIAE 23F, IMMUNE SYSTEM
4hjj:L (ILE115) to (ILE220) STRUCTURE REVEALS FUNCTION OF THE DUAL VARIABLE DOMAIN IMMUNOGLOBULIN (DVD-IG) MOLECULE | DFAB COMPLEX, IL-18, DUAL VARIABLE DOMAIN IMMUNOGLOBULIN, IMMUNE SYSTEM
3eyf:A (VAL3) to (ILE107) CRYSTAL STRUCTURE OF ANTI-HUMAN CYTOMEGALOVIRUS ANTIBODY 8F9 PLUS GB PEPTIDE | CYTOMEGALOVIRUS, ANTIBODY, IMMUNOGLOBULIN DOMAIN, CLEAVAGE ON PAIR OF BASIC RESIDUES, ENVELOPE PROTEIN, GLYCOPROTEIN, HOST-VIRUS INTERACTION, MEMBRANE, TRANSMEMBRANE, VIRION, IMMUNE SYSTEM
1bgx:L (ASP1) to (LEU106) TAQ POLYMERASE IN COMPLEX WITH TP7, AN INHIBITORY FAB | DNA POLYMERASE, FAB, PCR, INHIBITION, HELIX-COIL DYNAMICS, INHIBITOR DESIGN, COMPLEX (POLYMERASE/INHIBITOR)
4hlz:H (ILE4) to (ILE108) CRYSTAL STRUCTURE OF FAB C179 IN COMPLEX WITH A H2N2 INFLUENZA VIRUS HEMAGGLUTININ | NEUTRALIZING ANTIBODIES, ANTIBODY AFFINITY, ANTIGENS, EPITOPES, GLYCOSYLATION, HEMAGGLUTININ GLYCOPROTEINS, IMMUNOGLOBULIN FAB FRAGMENTS, H2N2 SUBTYPE, INFLUENZA VACCINES, AVIAN FLU, ENVELOPE PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4hlz:J (ILE4) to (ILE108) CRYSTAL STRUCTURE OF FAB C179 IN COMPLEX WITH A H2N2 INFLUENZA VIRUS HEMAGGLUTININ | NEUTRALIZING ANTIBODIES, ANTIBODY AFFINITY, ANTIGENS, EPITOPES, GLYCOSYLATION, HEMAGGLUTININ GLYCOPROTEINS, IMMUNOGLOBULIN FAB FRAGMENTS, H2N2 SUBTYPE, INFLUENZA VACCINES, AVIAN FLU, ENVELOPE PROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
2boc:B (ILE2) to (ALA109) POTASSIUM CHANNEL KCSA-FAB COMPLEX IN THALLIUM WITH TETRAETHYLARSONIUM (TEAS) | IMMUNE SYSTEM/TRANSPORT PROTEIN, COMPLEX (ANTIBODY/ION CHANNEL), POTASSIUM CHANNEL, ION TRANSPORT, IONIC CHANNEL, PROTEIN- ANTIBODY FAB COMPLEX
4x80:L (GLN3) to (ILE106) CRYSTAL STRUCTURE OF MURINE 7B4 FAB MONOCLONAL ANTIBODY AGAINST ADAMTS5 | MONOCLONAL, IMMUNE SYSTEM
4xak:L (ILE2) to (ILE106) CRYSTAL STRUCTURE OF POTENT NEUTRALIZING ANTIBODY M336 IN COMPLEX WITH MERS CO-V RBD | MERS-COV RBD, ANTIBODY M336, NEUTRALIZATION, IMMUNE SYSTEM
3fct:C (LEU2) to (ILE106) MATURE METAL CHELATASE CATALYTIC ANTIBODY WITH HAPTEN | METAL CHELATASE, CATALYTIC ANTIBODY, FAB FRAGMENT, IMMUNE SYSTEM
1c08:A (ILE2) to (ILE106) CRYSTAL STRUCTURE OF HYHEL-10 FV-HEN LYSOZYME COMPLEX | ANTIGEN-ANTIBODY COMPLEX, IMMUNE SYSTEM/HYDROLASE COMPLEX
4hwb:L (GLU1) to (ILE103) CRYSTAL STRUCTURE OF ECTODOMAIN 3 OF THE IL-13 RECEPTOR ALPHA 1 IN COMPLEX WITH A HUMAN NEUTRALIZING MONOCLONAL ANTIBODY FRAGMENT | FAB, FNIII, CYTOKINE SIGNALING, IMMUNE SYSTEM
4hwe:L (GLU1) to (ILE103) CRYSTAL STRUCTURE OF ECTODOMAIN 3 OF THE IL-13 RECEPTOR ALPHA1 IN COMPLEX WITH A HUMAN NEUTRALIZING MONOCLONAL ANTIBODY FRAGMENT | FAB, FNIII, IMMUNE SYSTEM
4xhq:A (GLN104) to (GLU205) RE-REFINEMENT THE CRYSTAL STRUCTURE OF DSCAM1 ISOFORM 1.34, N-TERMINAL FOUR IG DOMAINS | IG FOLD, CELL ADHESION
1om3:L (VAL2) to (ILE106) FAB 2G12 UNLIGANDED | FAB 2G12, THREE-DIMENSIONAL DOMAIN SWAP, IMMUNE SYSTEM
1om3:M (VAL2) to (ILE106) FAB 2G12 UNLIGANDED | FAB 2G12, THREE-DIMENSIONAL DOMAIN SWAP, IMMUNE SYSTEM
3skj:M (ASP1) to (ILE106) STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF AN AGONISTIC ANTI-HUMAN EPHA2 MONOCLONAL ANTIBODY | FAB, RECEPTOR, IG FOLD, EPHRIN RECEPTOR, ANTIBODY, ANTIGEN, EXTRA- CELLULAR, IMMUNE SYSTEM
1cf8:L (VAL3) to (ALA109) CONVERGENCE OF CATALYTIC ANTIBODY AND TERPENE CYCLASE MECHANISMS: POLYENE CYCLIZATION DIRECTED BY CARBOCATION-PI INTERACTIONS | CATALYTIC ANTIBODY, TERPENOID SYNTHASE, CARBOCATION, CYCLIZATION CASCADE
1op3:L (VAL2) to (ILE106) CRYSTAL STRUCTURE OF FAB 2G12 BOUND TO MAN1->2MAN | DOMAIN-SWAPPED FAB 2G12; ANTI-CARBOHYDRATE ANTIBODY, IMMUNE SYSTEM
1ors:A (VAL3) to (ILE106) X-RAY STRUCTURE OF THE KVAP POTASSIUM CHANNEL VOLTAGE SENSOR IN COMPLEX WITH AN FAB | POTASSIUM CHANNEL, VOLTAGE-DEPENDENT, VOLTAGE SENSOR, KVAP, FAB COMPLEX, MEMBRANE PROTEIN
3so3:B (ILE2) to (ILE106) STRUCTURES OF FAB-PROTEASE COMPLEXES REVEAL A HIGHLY SPECIFIC NON- CANONICAL MECHANISM OF INHIBITION. | ANTIBODY-PROTEIN, PROTEIN-PROTEIN, PROTEASE INHIBITOR, DISEASE MUTATION, GLYCOPROTEIN, HYDROLASE, MEMBRANE, SERINE PROTEASE, SIGNAL-ANCHOR, TRANSMEMBRANE
1d6v:L (ILE2) to (ILE106) CONFORMATION EFFECTS IN BIOLOGICAL CATALYSIS INTRODUCED BY OXY-COPE ANTIBODY MATURATION | IMMUNE SYSTEM
1p7k:L (LEU2) to (LEU106) CRYSTAL STRUCTURE OF AN ANTI-SSDNA ANTIGEN-BINDING FRAGMENT (FAB) BOUND TO 4-(2-HYDROXYETHYL)PIPERAZINE-1-ETHANESULFONIC ACID (HEPES) | FAB, ANTIBODY, ANTI-DNA ANTIBODY, AUTOANTIBODY, LUPUS, HEPES, IMMUNE SYSTEM
1p7k:A (LEU2) to (LEU106) CRYSTAL STRUCTURE OF AN ANTI-SSDNA ANTIGEN-BINDING FRAGMENT (FAB) BOUND TO 4-(2-HYDROXYETHYL)PIPERAZINE-1-ETHANESULFONIC ACID (HEPES) | FAB, ANTIBODY, ANTI-DNA ANTIBODY, AUTOANTIBODY, LUPUS, HEPES, IMMUNE SYSTEM
4xpt:L (ASN2) to (MET107) X-RAY STRUCTURE OF DROSOPHILA DOPAMINE TRANSPORTER WITH SUBSITEB MUTATIONS D121G/S426M AND EL2 DELETION OF 162-201 IN COMPLEX WITH SUBSTRATE ANALOGUE 3,4 DICHLOROPHEN ETHYLAMINE | INTEGRAL MEMBRANE PROTEIN, ALL-ALPHA HELICAL ANTIDEPRESSANT COMPLEX, TRANSPORT PROTEIN-INHIBITOR COMPLEX, PROTEIN TRANSPORT-INHIBITOR COMPLEX
2cju:L (VAL2) to (ILE106) CRYSTAL STRUCTURE OF THE TEPC15-VK45.1 ANTI-2-PHENYL-5- OXAZOLONE NQ16-113.8 SCFV IN COMPLEX WITH PHOXGABA | SCFV, ANTIBODY, IMMUNOGLOBULIN, 2-PHENYL-5-OXAZOLONE, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
3g5x:C (LEU3) to (ILE106) ANTIBODIES SPECIFICALLY TARGETING A LOCALLY MISFOLDED REGION OF TUMOR ASSOCIATED EGFR | ANTIBODY, IMMUNE SYSTEM
4iof:D (MET4) to (ILE107) CRYSTAL STRUCTURE ANALYSIS OF FAB-BOUND HUMAN INSULIN DEGRADING ENZYME (IDE) | HYDROLASE, ZINC METALLOPROTEASE
4xtr:D (ILE3) to (ILE109) STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF PEP12 | MEMBRANE PROTEIN TARGETING COMPLEX, HYDROLASE-TRANSPORT PROTEIN COMPLEX
4xtr:F (ASP2) to (ILE109) STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF PEP12 | MEMBRANE PROTEIN TARGETING COMPLEX, HYDROLASE-TRANSPORT PROTEIN COMPLEX
4xvu:J (ILE3) to (ILE109) STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF NYV1 | MEMBRANE PROTEIN TARGETING COMPLEX, HYDROLASE-TRANSPORT PROTEIN COMPLEX
4xwo:D (ILE3) to (ILE109) STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF SEC22 | MEMBRANE PROTEIN TARGETING COMPLEX, HYDROLASE-TRANSPORT PROTEIN COMPLEX
4xwo:F (ILE3) to (ILE109) STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF SEC22 | MEMBRANE PROTEIN TARGETING COMPLEX, HYDROLASE-TRANSPORT PROTEIN COMPLEX
4xwo:L (ILE3) to (ILE109) STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF SEC22 | MEMBRANE PROTEIN TARGETING COMPLEX, HYDROLASE-TRANSPORT PROTEIN COMPLEX
2qqn:L (GLN3) to (ILE106) NEUROPILIN-1 B1 DOMAIN IN COMPLEX WITH A VEGF-BLOCKING FAB | VEGF RECEPTOR, SEMAPHORIN RECEPTOR, PHAGE-DERIVED ANTIBODY, ANGIOGENESIS, DEVELOPMENTAL PROTEIN, DIFFERENTIATION, GLYCOPROTEIN, HEPARAN SULFATE, MEMBRANE, NEUROGENESIS, PROTEOGLYCAN, SECRETED, TRANSMEMBRANE, HORMONE, SIGNALING PROTEIN
1dqd:L (VAL3) to (ILE105) CRYSTAL STRUCTURE OF FAB HGR-2 F6, A COMPETITIVE ANTAGONIST OF THE GLUCAGON RECEPTOR | GLUCAGON RECEPTOR, MONOCLONAL ANTIBODY, FAB, RECEPTOR ANTAGONIST, TYPICAL IMMUNOGLOBULIN FOLD, LIGHT CHAIN, HEAVY CHAIN, ANTIGEN BINDING SITE, COMPLEMENTARITY-DETERMINING REGIONS, IMMUNE SYSTEM
1dqj:A (ILE2) to (ILE106) CRYSTAL STRUCTURE OF THE ANTI-LYSOZYME ANTIBODY HYHEL-63 COMPLEXED WITH HEN EGG WHITE LYSOZYME | ANTIBODY, PROTEIN-PROTEIN COMPLEX, HEN EGG WHITE LYSOZYME, IMMUNE SYSTEM/HYDROLASE COMPLEX
1dqq:A (ILE2) to (ILE106) CRYSTAL STRUCTURE OF ANTI-LYSOZYME ANTIBODY HYHEL-63 | ANTI-LYSOZYME ANTIBODY, HYHEL-63, HEN EGG WHITE LYSOZYME, IMMUNE SYSTEM
3tcl:L (GLU1) to (ILE106) CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY CH04 | IG, IMMUNOGLOBULIN, IMMUNE SYSTEM
3tcl:B (GLU1) to (ILE106) CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY CH04 | IG, IMMUNOGLOBULIN, IMMUNE SYSTEM
4j8r:A (ASP1) to (ILE104) STRUCTURE OF AN OCTAPEPTIDE REPEAT OF THE PRION PROTEIN BOUND TO THE POM2 FAB ANTIBODY FRAGMENT | IMMUNOGLOBULIN FOLD, FAB, ANTIBODY, OCTAPEPTIDE REPEAT, MOUSE PRION PROTEIN, IMMUNE SYSTEM
4y89:A (GLN2) to (PHE109) CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF CEACAM7 | CELL ADHESION
2dqc:L (ILE2) to (ILE106) CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT(HY33F) COMPLEXED WITH HEN EGG LYSOZYME | ANTIGEN-ANTIBODY COMPLEX, MUTANT, IMMUNE SYSTEM/HYDROLASE COMPLEX
2dqe:L (ILE2) to (ILE106) CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT (HY53A) COMPLEXED WITH HEN EGG LYSOZYME | ANTIGEN-ANTIBODY COMPLEX, MUTANT, IMMUNE SYSTEM/HYDROLASE COMPLEX
2dqf:A (ILE2) to (ILE106) CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT (Y33AY53A) COMPLEXED WITH HEN EGG LYSOZYME | ANTIGEN-ANTIBODY COMPLEX, MUTANT, IMMUNE SYSTEM/HYDROLASE COMPLEX
2dqf:D (ILE2) to (ILE106) CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT (Y33AY53A) COMPLEXED WITH HEN EGG LYSOZYME | ANTIGEN-ANTIBODY COMPLEX, MUTANT, IMMUNE SYSTEM/HYDROLASE COMPLEX
2dqg:L (ILE2) to (ILE106) CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT (HY53F) COMPLEXED WITH HEN EGG LYSOZYME | ANTIGEN-ANTIBODY COMPLEX, MUTANT, IMMUNE SYSTEM/HYDROLASE COMPLEX
2dqh:L (ILE2) to (ILE106) CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT (HY58A) COMPLEXED WITH HEN EGG LYSOZYME | ANTIGEN-ANTIBODY COMPLEX, MUTANT, IMMUNE SYSTEM/HYDROLASE COMPLEX
2dqj:L (ILE2) to (ILE106) CRYSTAL STRUCTURE OF HYHEL-10 FV (WILD-TYPE) COMPLEXED WITH HEN EGG LYSOZYME AT 1.8A RESOLUTION | ANTIGEN-ANTIBODY COMPLEX, IMMUNE SYSTEM/HYDROLASE COMPLEX
1qac:B (ILE302) to (ILE406) CHANGE IN DIMERIZATION MODE BY REMOVAL OF A SINGLE UNSATISFIED POLAR RESIDUE | BETA BARREL IMMUNOGLOBULIN VL DOMAIN DIMER, FLIPPED DOMAIN DIMER, IMMUNE SYSTEM
4ydk:L (ASP1) to (ILE106) CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY C38- VRC16.01 IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057 GP120 | ANTIBODY, HIV-1, IMMUNE SYSTEM
4ydl:L (VAL3) to (MET106) CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY C38- VRC18.02 IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057GP120 | ANTIBODY, HIV-1, IMMUNE SYSTEM
4ydl:C (VAL3) to (MET106) CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY C38- VRC18.02 IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057GP120 | ANTIBODY, HIV-1, IMMUNE SYSTEM
4ydv:L (ILE2) to (LEU106) STRUCTURE OF THE ANTIBODY 7B2 THAT CAPTURES HIV-1 VIRIONS | IGG, HIV, ANTIBODY, HIV GP41 ENVELOPE PROTEIN, IMMUNE SYSTEM
4ydv:A (ILE2) to (LEU106) STRUCTURE OF THE ANTIBODY 7B2 THAT CAPTURES HIV-1 VIRIONS | IGG, HIV, ANTIBODY, HIV GP41 ENVELOPE PROTEIN, IMMUNE SYSTEM
4jm2:B (VAL3) to (THR109) CRYSTAL STRUCTURE OF PGT 135 FAB IN COMPLEX WITH GP120 CORE PROTEIN FROM HIV-1 STRAIN JR-FL BOUND TO CD4 AND 17B FAB | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
4jpi:B (ILE2) to (ILE108) CRYSTAL STRUCTURE OF A PUTATIVE VRC01 GERMLINE PRECURSOR FAB | ANTI-HIV-1, GP120, CD4 BINDING SITE-TARGETING, VRC01 BROADLY NEUTRALIZING ANTIBODY, IMMUNE SYSTEM
4jpk:L (ILE2) to (ILE108) CRYSTAL STRUCTURE OF THE GERMLINE-TARGETING HIV-1 GP120 ENGINEERED OUTER DOMAIN EOD-GT6 IN COMPLEX WITH A PUTATIVE VRC01 GERMLINE PRECURSOR FAB | HIV-1 GP120, CD4 BINDING, VRC01-LIKE BROADLY NEUTRALIZING ANTIBODIES, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
4jqi:L (ILE3) to (ILE107) STRUCTURE OF ACTIVE BETA-ARRESTIN1 BOUND TO A G PROTEIN-COUPLED RECEPTOR PHOSPHOPEPTIDE | ARRESTIN, GPCR, G-PROTEIN COUPLED RECEPTOR, SIGNALING, SIGNALING PROTEIN
4jre:C (LEU3) to (ALA108) CRYSTAL STRUCTURE OF NITRATE/NITRITE EXCHANGER NARK WITH NITRITE BOUND | TRANSPORTER, IMMUNOGLOBULIN, MAJOR FACILITATOR SUPERFAMILY, EXCHANGER, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX
2uud:K (VAL2) to (ILE106) CRYSTAL STRUCTURE OF THE TEPC15-VK45.1 ANTI-2-PHENYL-5- OXAZOLONE NQ10-1.12 SCFV IN COMPLEX WITH THE HAPTEN | SCFV, ANTIBODY, IMMUNOGLOBULIN, 2-PHENYL-5-OXAZOLONE, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
3u30:B (ILE2) to (ILE106) CRYSTAL STRUCTURE OF A LINEAR-SPECIFIC UBIQUITIN FAB BOUND TO LINEAR UBIQUITIN | IMMUNE SYSTEM
1r24:A (MET4) to (ALA109) FAB FROM MURINE IGG3 KAPPA | PRELIMINARY, IMMUNE SYSTEM
2uyl:V (GLU1) to (ALA114) CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1 | FAB FRAGMENT, MONOCLONAL ANTIBODY, IMMUNE SYSTEM, IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN C REGION, ANTI-LPS VIBRIO CHOLERAE
1r3i:L (ILE2) to (ALA109) POTASSIUM CHANNEL KCSA-FAB COMPLEX IN RB+ | MEMBRANE PROTEIN, POTASSIUM CHANNEL, KCSA-FAB COMPLEX, RUBIDIUM
3ubx:L (ASP1) to (LEU106) CRYSTAL STRUCTURE OF THE MOUSE CD1D-C20:2-AGALCER-L363 MAB FAB COMPLEX | IMMUNOLOGY, MOUSE CD1D/NKT, MAB, IMMUNE SYSTEM
3ubx:I (ASP1) to (LEU106) CRYSTAL STRUCTURE OF THE MOUSE CD1D-C20:2-AGALCER-L363 MAB FAB COMPLEX | IMMUNOLOGY, MOUSE CD1D/NKT, MAB, IMMUNE SYSTEM
4k23:L (VAL2) to (ALA109) STRUCTURE OF ANTI-UPAR FAB ATN-658 | IMMUNE SYSTEM
3hi5:L (GLN3) to (ILE105) CRYSTAL STRUCTURE OF FAB FRAGMENT OF AL-57 | FAB FRAGMENT, LIGAND MIMETIC, INTEGRIN, I DOMAIN, CELL ADHESION, IMMUNE SYSTEM
4yr6:B (ILE2) to (ILE106) FAB FRAGMENT OF 5G6 IN COMPLEX WITH EPITOPE PEPTIDE | GPIBA SHEDDING INHIBITOR, 5G6, KL10, IMMUNE SYSTEM
4yr6:E (GLN3) to (ILE106) FAB FRAGMENT OF 5G6 IN COMPLEX WITH EPITOPE PEPTIDE | GPIBA SHEDDING INHIBITOR, 5G6, KL10, IMMUNE SYSTEM
2v5s:A (GLN104) to (LEU201) STRUCTURAL BASIS FOR DSCAM ISOFORM SPECIFICITY | DOWN SYNDROME, IMMUNOGLOBULIN DOMAIN, CELL ADHESION, MEMBRANE, DEVELOPMENTAL PROTEIN
4k7p:X (ASP1) to (ILE106) GENERATION AND CHARACTERIZATION OF A UNIQUE REAGENT THAT RECOGNIZES A PANEL OF RECOMBINANT HUMAN MONOCLONAL ANTIBODY THERAPEUTICS IN THE PRESENCE OF ENDOGENOUS HUMAN IGG | IMMUNOGLOBULIN, IMMUNE SYSTEM
4k7p:L (ASP1) to (LEU106) GENERATION AND CHARACTERIZATION OF A UNIQUE REAGENT THAT RECOGNIZES A PANEL OF RECOMBINANT HUMAN MONOCLONAL ANTIBODY THERAPEUTICS IN THE PRESENCE OF ENDOGENOUS HUMAN IGG | IMMUNOGLOBULIN, IMMUNE SYSTEM
1fvc:A (ILE2) to (ILE106) X-RAY STRUCTURES OF THE ANTIGEN-BINDING DOMAINS FROM THREE VARIANTS OF HUMANIZED ANTI-P185-HER2 ANTIBODY 4D5 AND COMPARISON WITH MOLECULAR MODELING | IMMUNOGLOBULIN
3ulu:L (ASP1) to (ILE106) STRUCTURE OF QUATERNARY COMPLEX OF HUMAN TLR3ECD WITH THREE FABS (FORM1) | TOLL-LIKE RECEPTOR-3, TLR3,INNATE IMMUNITY, LEUCINE RICH REPEAT, LRR, IMMUNOGLOBULIN, IMMUNE SYSTEM
3ulu:E (GLN3) to (LEU106) STRUCTURE OF QUATERNARY COMPLEX OF HUMAN TLR3ECD WITH THREE FABS (FORM1) | TOLL-LIKE RECEPTOR-3, TLR3,INNATE IMMUNITY, LEUCINE RICH REPEAT, LRR, IMMUNOGLOBULIN, IMMUNE SYSTEM
3ulv:L (ASP1) to (ILE106) STRUCTURE OF QUATERNARY COMPLEX OF HUMAN TLR3ECD WITH THREE FABS (FORM2) | TOLL-LIKE RECEPTOR-3, TLR3, INNATE IMMUNITY, LEUCINE RICH REPEAT, LRR, IMMUNOGLOBULIN, IMMUNE SYSTEM
1g7h:A (ILE2) to (ILE106) CRYSTAL STRUCTURE OF HEN EGG WHITE LYSOZYME (HEL) COMPLEXED WITH THE MUTANT ANTI-HEL MONOCLONAL ANTIBODY D1.3(VLW92A) | HYDROLASE INHIBITOR/HYDROLASE
1rz7:L (ILE2) to (ILE106) CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 48D | HIV-1; GP120; CD4I; ANTIBODIES; TYROSINE SULFATION; VH-GENE USAGE, IMMUNE SYSTEM
1rzg:D (GLN3) to (ILE106) CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120 REACTIVE ANTIBODY 412D | HIV-1; GP120; CD4I; ANTIBODIES; TYROSINE SULFATION; VH-GENE USAGE, IMMUNE SYSTEM
1rzi:E (ILE2) to (ILE106) CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 47E FAB | HIV-1; GP120; CD4I; ANTIBODIES; TYROSINE SULFATION; VH-GENE USAGE, IMMUNE SYSTEM
1rzi:K (ILE2) to (ILE106) CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 47E FAB | HIV-1; GP120; CD4I; ANTIBODIES; TYROSINE SULFATION; VH-GENE USAGE, IMMUNE SYSTEM
2fjf:L (ILE2) to (ILE106) STRUCTURE OF THE G6 FAB, A PHAGE DERIVED VEGF BINDING FAB | ANTIBODY, FAB, DODECAMER, IMMUNE SYSTEM
1s5i:L (VAL2) to (ILE106) FAB (LNKB-2) OF MONOCLONAL ANTIBODY TO HUMAN INTERLEUKIN-2, CRYSTAL STRUCTURE | MONOCLONAL ANTIBODY, ANTIGEN-BINDING FRAGMENT, INTERLEUKIN- 2, X-RAY ANALYSIS, CRYSTAL STRUCTURE, IMMUNE SYSTEM
4zd3:L (ILE2) to (ILE126) STRUCTURE OF A TRANSGLUTAMINASE 2-SPECIFIC AUTOANTIBODY FAB FRAGMENT | TRANSGLUTAMINASE 2, ANTIBODY, FAB FRAGMENT, CELIAC DISEASE, IMMUNE SYSTEM
1s78:C (ILE2) to (ILE106) INSIGHTS INTO ERBB SIGNALING FROM THE STRUCTURE OF THE ERBB2- PERTUZUMAB COMPLEX | RECEPTOR-ANTIBODY COMPLEX, FAB FRAGMENT, CYSTEINE-RICH DOMAIN, LEUCINE-RICH REPEAT, TRANSFERASE
1s78:E (ILE2) to (ILE106) INSIGHTS INTO ERBB SIGNALING FROM THE STRUCTURE OF THE ERBB2- PERTUZUMAB COMPLEX | RECEPTOR-ANTIBODY COMPLEX, FAB FRAGMENT, CYSTEINE-RICH DOMAIN, LEUCINE-RICH REPEAT, TRANSFERASE
3v0v:L (ASP1) to (ILE106) FAB WN1 222-5 UNLIGANDED | BETA SHEETS, ANTIBODY, FAB, IMMUNE SYSTEM
3v0v:B (ILE2) to (ILE106) FAB WN1 222-5 UNLIGANDED | BETA SHEETS, ANTIBODY, FAB, IMMUNE SYSTEM
4zfg:L (ILE2) to (THR109) DUAL-SPECIFICITY FAB 5A12 IN COMPLEX WITH ANGIOPOIETIN 2 | FAB, DAF, ANGIOGENESIS, TIE RECEPTOR, SIGNALING PROTEIN-IMMUNE SYSTEM COMPLEX
4zfo:L (ASP1) to (LEU106) J22.9-XI: CHIMERIC MOUSE/HUMAN ANTIBODY AGAINST HUMAN BCMA (CD269) | ANTIBODY FAB-LIGAND COMPLEX ANTI-BCMA ANTI-TUMOR, IMMUNE SYSTEM
4zfo:B (ASP1) to (LEU106) J22.9-XI: CHIMERIC MOUSE/HUMAN ANTIBODY AGAINST HUMAN BCMA (CD269) | ANTIBODY FAB-LIGAND COMPLEX ANTI-BCMA ANTI-TUMOR, IMMUNE SYSTEM
3v6f:B (MET3) to (ILE113) CRYSTAL STRUCTURE OF AN ANTI-HBV E-ANTIGEN MONOCLONAL FAB FRAGMENT (E6), UNBOUND | IMMUNOGLOBULIN DOMAIN, ANTIBODY FAB FRAGMENT, IMMUNE SYSTEM
3v6f:D (ASN1) to (ILE113) CRYSTAL STRUCTURE OF AN ANTI-HBV E-ANTIGEN MONOCLONAL FAB FRAGMENT (E6), UNBOUND | IMMUNOGLOBULIN DOMAIN, ANTIBODY FAB FRAGMENT, IMMUNE SYSTEM
3v6f:F (MET3) to (ILE113) CRYSTAL STRUCTURE OF AN ANTI-HBV E-ANTIGEN MONOCLONAL FAB FRAGMENT (E6), UNBOUND | IMMUNOGLOBULIN DOMAIN, ANTIBODY FAB FRAGMENT, IMMUNE SYSTEM
3v6f:L (ASN1) to (ILE113) CRYSTAL STRUCTURE OF AN ANTI-HBV E-ANTIGEN MONOCLONAL FAB FRAGMENT (E6), UNBOUND | IMMUNOGLOBULIN DOMAIN, ANTIBODY FAB FRAGMENT, IMMUNE SYSTEM
2vxv:L (VAL3) to (ILE106) CRYSTAL STRUCTURE OF HUMAN IGG ABT-325 FAB FRAGMENT | IMMUNE SYSTEM, IL-18, FAB, TH1/TH2 CELLS, AUTOIMMUNITY
1svz:A (ILE2) to (ILE111) CRYSTAL STRUCTURE OF THE SINGLE-CHAIN FV FRAGMENT 1696 IN COMPLEX WITH THE EPITOPE PEPTIDE CORRESPONDING TO N- TERMINUS OF HIV-2 PROTEASE | ANTIBODY-ANTIGEN COMPLEX; HIV INHIBITING ANTIBODY, IMMUNE SYSTEM
1svz:B (ILE2) to (ILE111) CRYSTAL STRUCTURE OF THE SINGLE-CHAIN FV FRAGMENT 1696 IN COMPLEX WITH THE EPITOPE PEPTIDE CORRESPONDING TO N- TERMINUS OF HIV-2 PROTEASE | ANTIBODY-ANTIGEN COMPLEX; HIV INHIBITING ANTIBODY, IMMUNE SYSTEM
3vga:B (VAL3) to (ILE106) CRYSTAL STRUCTURE OF HUMAN ADENOSINE A2A RECEPTOR WITH AN ALLOSTERIC INVERSE-AGONIST ANTIBODY AT 3.1 A RESOLUTION | 7 TRANSMEMBRANE RECEPTOR, SIGNAL TRANSDUCTION, SIGNALING PROTEIN
2ghw:B (THR134) to (VAL238) CRYSTAL STRUCTURE OF SARS SPIKE PROTEIN RECEPTOR BINDING DOMAIN IN COMPLEX WITH A NEUTRALIZING ANTIBODY, 80R | SARS, S PROTEIN, NEUTRALIZING ANTIBODY, VIRUS/VIRAL PROTEIN/ANTIBIOTIC COMPLEX
2ghw:D (GLU133) to (VAL238) CRYSTAL STRUCTURE OF SARS SPIKE PROTEIN RECEPTOR BINDING DOMAIN IN COMPLEX WITH A NEUTRALIZING ANTIBODY, 80R | SARS, S PROTEIN, NEUTRALIZING ANTIBODY, VIRUS/VIRAL PROTEIN/ANTIBIOTIC COMPLEX
1t66:L (VAL2) to (ILE111) THE STRUCTURE OF FAB WITH INTERMEDIATE AFFINITY FOR FLUORESCEIN. | ANTIBODY, FAB, FLUORESCEIN, IMMUNE SYSTEM
1t66:C (VAL2) to (ILE111) THE STRUCTURE OF FAB WITH INTERMEDIATE AFFINITY FOR FLUORESCEIN. | ANTIBODY, FAB, FLUORESCEIN, IMMUNE SYSTEM
1h8o:B (ASP4) to (LEU109) THREE-DIMENSIONAL STRUCTURE OF ANTI-AMPICILLIN SINGLE CHAIN FV FRAGMENT. | ANTIBODY, FV FRAGMENT, ANTI-AMPICILLIN
1h8s:B (ASP4) to (LEU109) THREE-DIMENSIONAL STRUCTURE OF ANTI-AMPICILLIN SINGLE CHAIN FV FRAGMENT COMPLEXED WITH THE HAPTEN. | ANTI-AMPICILLIN ANTIBODIES
4lci:L (ILE2) to (ILE107) ANTI CANINE CD28 ANTIBODY, 1C6 | IMMUNOGLOBULIN, ANTIBODY, CD28, IMMUNE SYSTEM
4zso:C (VAL3) to (LEU105) CRYSTAL STRUCTURE OF A COMPLEX BETWEEN B7-H6, A TUMOR CELL LIGAND FOR NATURAL CYTOTOXICITY RECEPTOR NKP30, AND AN INHIBITORY ANTIBODY | TUMOR LIGAND B7-H6, ANTIBODY, IMMUNE SYSTEM
3inu:N (GLU1) to (ILE106) CRYSTAL STRUCTURE OF AN UNBOUND KZ52 NEUTRALIZING ANTI-EBOLAVIRUS ANTIBODY. | ANTIBODY FRAGMENT (FAB), IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
1hez:C (ASP1) to (ILE106) ANTIBODY-ANTIGEN COMPLEX | ANTIBODY, SUPERANTIGEN
1hil:C (VAL3) to (LEU106) STRUCTURAL EVIDENCE FOR INDUCED FIT AS A MECHANISM FOR ANTIGEN-ANTIBODY RECOGNITION | IMMUNOGLOBULIN
1hq4:A (VAL3) to (LEU106) STRUCTURE OF NATIVE CATALYTIC ANTIBODY HA5-19A4 | CATALYTIC ANTIBODY, TERPENOID SYNTHASE, CARBOCATION, CYCLIZATION CASCADE, IMMUNOGLOBULIN, IMMUNE SYSTEM
1hq4:C (VAL3) to (LEU106) STRUCTURE OF NATIVE CATALYTIC ANTIBODY HA5-19A4 | CATALYTIC ANTIBODY, TERPENOID SYNTHASE, CARBOCATION, CYCLIZATION CASCADE, IMMUNOGLOBULIN, IMMUNE SYSTEM
4zyk:B (ILE2) to (THR109) CRYSTAL STRUCTURE OF QUATERNARY-SPECIFIC RSV-NEUTRALIZING HUMAN ANTIBODY AM14 | IG DOMAIN, FAB, IMMUNE SYSTEM
3vrl:L (ASP1) to (ILE106) CRYSTAL STRUCTURE OF BMJ4 P24 CAPSID PROTEIN IN COMPLEX WITH A10F9 FAB | HIV-1 CAPSIDE P24, CAPSID PROTEIN, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
1tzh:A (GLN3) to (ILE106) CRYSTAL STRUCTURE OF THE FAB YADS1 COMPLEXED WITH H-VEGF | PHAGE DISPLAY, ANTIBODY LIBRARY, PROTEIN ENGINEERING, IMMUNE SYSTEM
1hzh:L (GLU1) to (ARG106) CRYSTAL STRUCTURE OF THE INTACT HUMAN IGG B12 WITH BROAD AND POTENT ACTIVITY AGAINST PRIMARY HIV-1 ISOLATES: A TEMPLATE FOR HIV VACCINE DESIGN | IMMUNOGLOBULIN, ANTIBODY, B12, IMMUNE SYSTEM
1hzh:M (GLU1) to (ARG106) CRYSTAL STRUCTURE OF THE INTACT HUMAN IGG B12 WITH BROAD AND POTENT ACTIVITY AGAINST PRIMARY HIV-1 ISOLATES: A TEMPLATE FOR HIV VACCINE DESIGN | IMMUNOGLOBULIN, ANTIBODY, B12, IMMUNE SYSTEM
3vw3:L (LEU3) to (ILE106) ANTIBODY 64M-5 FAB IN COMPLEX WITH A DOUBLE-STRANDED DNA (6-4) PHOTOPRODUCT | PROTEIN-DNA COMPLEX, DNA (6-4) PHOTOPRODUCT, IMMUNOGLOBULIN, IMMUNE SYSTEM-DNA COMPLEX
4lri:B (VAL3) to (ILE111) ANTI CMV FAB FRAGMENT | FAB FRAGMENT, CMV NEUTRALIZING ANTIBODY, GLYCOPROTEIN H OR GH FROM CMV, IMMUNE SYSTEM
1i3g:L (ASP1) to (LEU147) CRYSTAL STRUCTURE OF AN AMPICILLIN SINGLE CHAIN FV, FORM 1, FREE | ANTIBODY FV FRAGMENT, ANTIBIOTIC
3w12:D (ILE2) to (ILE111) INSULIN RECEPTOR ECTODOMAIN CONSTRUCT COMPRISING DOMAINS L1-CR IN COMPLEX WITH HIGH-AFFINITY INSULIN ANALOGUE [D-PRO-B26]-DTI-NH2, ALPHA-CT PEPTIDE(704-719) AND FAB 83-7 | CELL SURFACE RECEPTOR/IMMUNE SYSTEM, INSULIN RECEPTOR, IR ECTODOMAIN, CT PEPTIDE, INSULIN, HORMONE RECEPTOR-HORMONE-IMMUNE SYSTEM COMPLEX
2ht2:D (ASP1) to (ILE105) STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL Y445H MUTANT AND FAB COMPLEX | CLC FAMILY OF CHANNEL AND TRANSPORTERS, H+/CL- ANTIPORTER, MEMBRANE PROTEIN, FAB COMPLEX
2ht3:D (ASP1) to (ILE105) STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL Y445L MUTANT AND FAB COMPLEX | CLC FAMILY OF CHANNEL AND TRANSPORTERS, H+/CL- ANTIPORTER, MEMBRANE PROTEIN, FAB COMPLEX
2ht4:D (ASP1) to (ILE105) STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL Y445W MUTANT AND FAB COMPLEX | CLC FAMILY OF CHANNEL AND TRANSPORTERS, H+/CL- ANTIPORTER, MEMBRANE PROTEIN, FAB COMPLEX
1u6a:L (GLU1) to (THR109) CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING ANTI-HIV FAB F105 | IMMUNOGLOBULIN, FAB, F105, GP120, HIV, IMMUNE SYSTEM
4lve:A (ASP1) to (ILE106) LEN K30T MUTANT: A DOMAIN FLIP AS A RESULT OF A SINGLE AMINO ACID SUBSTITUTION | IMMUNOGLOBULIN, KAPPA-IV, LIGHT CHAIN DIMER
5a3i:D (VAL3) to (ILE111) CRYSTAL STRUCTURE OF A COMPLEX FORMED BETWEEN FLD194 FAB AND TRANSMISSIBLE MUTANT H5 HAEMAGGLUTININ | VIRAL PROTEIN, HAEMAGGLUTININ, NEUTRALIZING ANTIBODY, BIRD FLU, H5N1, INFLUENZA VIRUS, GLYCOPROTEIN
5a3i:H (ILE2) to (ILE111) CRYSTAL STRUCTURE OF A COMPLEX FORMED BETWEEN FLD194 FAB AND TRANSMISSIBLE MUTANT H5 HAEMAGGLUTININ | VIRAL PROTEIN, HAEMAGGLUTININ, NEUTRALIZING ANTIBODY, BIRD FLU, H5N1, INFLUENZA VIRUS, GLYCOPROTEIN
1iai:L (ASP1) to (ILE106) IDIOTYPE-ANTI-IDIOTYPE FAB COMPLEX | COMPLEX (IMMUNOGLOBULIN IGG1/IGG2A)
1ic4:L (ILE2) to (ILE106) CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT(HD32A)-HEN LYSOZYME COMPLEX | ANTIGEN-ANTIBODY COMPLEX, HYHEL-10, ANTI-HEN EGG WHITE LYSOZYME ANTIBODY, PROTEIN BINDING/HYDROLASE COMPLEX
1ic7:L (ILE2) to (ILE106) CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT(HD32A99A)-HEN LYSOZYME COMPLEX | ANTIGEN-ANTIBODY COMPLEX, HYHEL-10, ANTI-HEN EGG WHITE LYSOZYME ANTIBODY, PROTEIN BINDING/HYDROLASE COMPLEX
1igj:C (VAL2) to (ILE106) 26-10 FAB:DIGOXIN COMPLEX-AFFINITY AND SPECIFICITY DUE TO SURFACE COMPLEMENTARITY | IMMUNOGLOBULIN
1igt:C (ILE2) to (ILE106) STRUCTURE OF IMMUNOGLOBULIN | INTACT IMMUNOGLOBULIN V REGION C REGION, IMMUNOGLOBULIN
2i60:L (ASP1) to (ILE106) CRYSTAL STRUCTURE OF [PHE23]M47, A SCORPION-TOXIN MIMIC OF CD4, IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B | HIV-1, GP120, YU2, SCORPION TOXIN, CD4 MIMIC, [PHE23]M47, ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
2i60:Q (VAL3) to (ILE106) CRYSTAL STRUCTURE OF [PHE23]M47, A SCORPION-TOXIN MIMIC OF CD4, IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B | HIV-1, GP120, YU2, SCORPION TOXIN, CD4 MIMIC, [PHE23]M47, ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3w9d:B (GLU1) to (ILE106) STRUCTURE OF HUMAN MONOCLONAL ANTIBODY E317 FAB | IGG FOLD, HSV GD, IMMUNE SYSTEM
3w9d:D (GLU1) to (ILE106) STRUCTURE OF HUMAN MONOCLONAL ANTIBODY E317 FAB | IGG FOLD, HSV GD, IMMUNE SYSTEM
4m62:L (GLU1) to (VAL110) ONTOGENY OF RECOGNITION SPECIFICITY AND FUNCTIONALITY FOR THE ANTI-HIV NEUTRALIZING ANTIBODY 4E10 | GEP, 4E10 GERMLINE, IMMUNOGLOBULIN, ANTIBOODY, HIV, IMMUNE SYSTEM
4m7z:C (ILE2) to (LEU106) UNLIGANDED 1 CRYSTAL STRUCTURE OF S25-26 FAB | BETA-SANDWICH, CARBOHYDRATE/SUGAR BINDING, IMMUNE SYSTEM
3wd5:L (ASP1) to (ILE106) CRYSTAL STRUCTURE OF TNFALPHA IN COMPLEX WITH ADALIMUMAB FAB FRAGMENT | ANTIBODY BINDING EPITOPE, IMMUNE SYSTEM
2x1x:R (ASP225) to (HIS325) CRYSTAL STRUCTURE OF VEGF-C IN COMPLEX WITH DOMAINS 2 AND 3 OF VEGFR2 IN A TETRAGONAL CRYSTAL FORM | HORMONE-SIGNALING PROTEIN COMPLEX, ANGIOGENESIS, GLYCOPROTEIN, HOST-VIRUS INTERACTION, RECEPTOR, LYMPHANGIOGENESIS, IMMUNOGLOBULIN DOMAIN, DEVELOPMENTAL PROTEIN, MITOGEN
3wfd:L (GLN3) to (LEU106) REDUCED AND ACETALDOXIME-BOUND CYTOCHROME C-DEPENDENT NITRIC OXIDE REDUCTASE (CNOR) FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH ANTIBODY FRAGMENT | METAL-BINDING, MEMBRANE PROTEIN, IMMUNE SYSTEM-OXIDOREDUCTASE COMPLEX
3wfe:L (GLN3) to (LEU106) REDUCED AND CYANIDE-BOUND CYTOCHROME C-DEPENDENT NITRIC OXIDE REDUCTASE (CNOR) FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH ANTIBODY FRAGMENT | METAL-BINDING, MEMBRANE PROTEIN, IMMUNE SYSTEM-OXIDOREDUCTASE COMPLEX
1j1o:L (ILE2) to (ILE106) CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT LY50F COMPLEXED WITH HEN EGG WHITE LYSOZYME | ANTIGEN-ANTIBODY COMPLEX, IMMUNE SYSTEM/HYDROLASE COMPLEX
1j1p:L (ILE2) to (ILE106) CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT LS91A COMPLEXED WITH HEN EGG WHITE LYSOZYME | ANTIGEN-ANTIBODY COMPLEX, IMMUNE SYSTEM/HYDROLASE COMPLEX
1j1x:L (ILE2) to (ILE106) CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT LS93A COMPLEXED WITH HEN EGG WHITE LYSOZYME | ANTIGEN-ANTIBODY COMPLEX, IMMUNE SYSTEM/HYDROLASE COMPLEX
1v7n:M (VAL2) to (ILE105) HUMAN THROMBOPOIETIN FUNCTIONAL DOMAIN COMPLEXED TO NEUTRALIZING ANTIBODY TN1 FAB | THROMBOPOIETIN, FAB FRAGMENT, COMPLEX (CYTOKINE/ANTIBODY), IMMUNE SYSTEM/CYTOKINE COMPLEX
1v7n:N (GLN1) to (ALA108) HUMAN THROMBOPOIETIN FUNCTIONAL DOMAIN COMPLEXED TO NEUTRALIZING ANTIBODY TN1 FAB | THROMBOPOIETIN, FAB FRAGMENT, COMPLEX (CYTOKINE/ANTIBODY), IMMUNE SYSTEM/CYTOKINE COMPLEX
4mqx:D (ASP1) to (ILE105) CLC-EC1 FAB COMPLEX CYSLESS A399C-A432C MUTANT | ALPHA HELICAL TRANSMEMBRANE PROTEIN, CL/H ANTIPORTER, METAL TRANSPORT, MEMBRANE PROTEIN
1vpo:L (VAL2) to (ILE111) CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-TESTOSTERONE FAB IN COMPLEX WITH TESTOSTERONE | FAB FRAGMENT, ANTI-STEROID, TESTOSTERONE COMPLEX, IMMUNE SYSTEM
2j88:L (ASP1) to (ILE106) HYALURONIDASE IN COMPLEX WITH A MONOCLONAL IGG FAB FRAGMENT | GLYCOPROTEIN, GLYCOSIDASE FAMILY 56, ZYMOGEN, ALLERGEN, 7- STRANDED (BETA/ALPHA) TIM BARREL, HYDROLASE, GLYCOSIDASE, IMMUNOGLOBULIN DOMAIN
3j70:B (ASP1) to (ILE106) MODEL OF GP120, INCLUDING VARIABLE REGIONS, IN COMPLEX WITH CD4 AND 17B | GP120, V1V2, CD4, 17B, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3j70:N (ASP1) to (ILE106) MODEL OF GP120, INCLUDING VARIABLE REGIONS, IN COMPLEX WITH CD4 AND 17B | GP120, V1V2, CD4, 17B, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3j70:S (ASP1) to (ILE106) MODEL OF GP120, INCLUDING VARIABLE REGIONS, IN COMPLEX WITH CD4 AND 17B | GP120, V1V2, CD4, 17B, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4mxw:V (ASP1) to (THR109) STRUCTURE OF HETEROTRIMERIC LYMPHOTOXIN LTA1B2 BOUND TO LYMPHOTOXIN BETA RECEPTOR LTBR AND ANTI-LTA FAB | TNF, TUMOR NECROSIS FACTOR, TNFR RECEPTOR, LYMPHOTOXIN BETA RECEPTOR, LYMPHOTOXIN ALPHA, LYMPHOID DEVELOPMENT, TUMOR IMMUNITY, AUTO- IMMUNITY, CYTOKINE-IMMUNE SYSTEM COMPLEX
4mxw:L (ASP1) to (ILE106) STRUCTURE OF HETEROTRIMERIC LYMPHOTOXIN LTA1B2 BOUND TO LYMPHOTOXIN BETA RECEPTOR LTBR AND ANTI-LTA FAB | TNF, TUMOR NECROSIS FACTOR, TNFR RECEPTOR, LYMPHOTOXIN BETA RECEPTOR, LYMPHOTOXIN ALPHA, LYMPHOID DEVELOPMENT, TUMOR IMMUNITY, AUTO- IMMUNITY, CYTOKINE-IMMUNE SYSTEM COMPLEX
3j8v:L (ASP1) to (LEU106) CRYO-EM RECONSTRUCTION OF QUASI-HPV16 COMPLEX WITH H16.14J FAB | L1 PENTAMER, QUASI-HPV16, L1 CAPSOMER, ROSIE ONLINE, VIRUS-IMMUNE SYSTEM COMPLEX
3j8v:J (ASP1) to (LEU106) CRYO-EM RECONSTRUCTION OF QUASI-HPV16 COMPLEX WITH H16.14J FAB | L1 PENTAMER, QUASI-HPV16, L1 CAPSOMER, ROSIE ONLINE, VIRUS-IMMUNE SYSTEM COMPLEX
3j8v:K (ASP1) to (LEU106) CRYO-EM RECONSTRUCTION OF QUASI-HPV16 COMPLEX WITH H16.14J FAB | L1 PENTAMER, QUASI-HPV16, L1 CAPSOMER, ROSIE ONLINE, VIRUS-IMMUNE SYSTEM COMPLEX
3j8v:M (ASP1) to (LEU106) CRYO-EM RECONSTRUCTION OF QUASI-HPV16 COMPLEX WITH H16.14J FAB | L1 PENTAMER, QUASI-HPV16, L1 CAPSOMER, ROSIE ONLINE, VIRUS-IMMUNE SYSTEM COMPLEX
3j8w:K (ILE2) to (LEU106) CRYO-EM RECONSTRUCTION OF QUASI-HPV16 COMPLEX WITH H263.A2 FAB | L1 PENTAMER, QUASI-HPV16, L1 CAPSOMER, ROSIE ONLINE, VIRUS-IMMUNE SYSTEM COMPLEX
4n1e:D (GLN3) to (ILE106) STRUCTURAL EVIDENCE FOR ANTIGEN RECEPTOR EVOLUTION | IMMUNOGLOBULIN LIGHT CHAIN VARIABLE DOMAIN, ANTIGEN-RECEPTOR INTERACTION, IG-FOLD, IMMUNE SYSTEM-HYDROLASE COMPLEX
4n1e:F (ILE2) to (GLU105) STRUCTURAL EVIDENCE FOR ANTIGEN RECEPTOR EVOLUTION | IMMUNOGLOBULIN LIGHT CHAIN VARIABLE DOMAIN, ANTIGEN-RECEPTOR INTERACTION, IG-FOLD, IMMUNE SYSTEM-HYDROLASE COMPLEX
4n1e:G (GLN3) to (ILE106) STRUCTURAL EVIDENCE FOR ANTIGEN RECEPTOR EVOLUTION | IMMUNOGLOBULIN LIGHT CHAIN VARIABLE DOMAIN, ANTIGEN-RECEPTOR INTERACTION, IG-FOLD, IMMUNE SYSTEM-HYDROLASE COMPLEX
4n1e:H (ASP1) to (ILE106) STRUCTURAL EVIDENCE FOR ANTIGEN RECEPTOR EVOLUTION | IMMUNOGLOBULIN LIGHT CHAIN VARIABLE DOMAIN, ANTIGEN-RECEPTOR INTERACTION, IG-FOLD, IMMUNE SYSTEM-HYDROLASE COMPLEX
3jab:L (ASP1) to (LEU106) DOMAIN ORGANIZATION AND CONFORMATIONAL PLASTICITY OF THE G PROTEIN EFFECTOR, PDE6 | PHOSPHODIESTERASE, PHOTORECEPTOR, HYDROLASE-IMMUNE SYSTEM COMPLEX
3jab:R (ASP1) to (LEU106) DOMAIN ORGANIZATION AND CONFORMATIONAL PLASTICITY OF THE G PROTEIN EFFECTOR, PDE6 | PHOSPHODIESTERASE, PHOTORECEPTOR, HYDROLASE-IMMUNE SYSTEM COMPLEX
5b8c:J (GLU1) to (ILE110) HIGH RESOLUTION STRUCTURE OF THE HUMAN PD-1 IN COMPLEX WITH PEMBROLIZUMAB FV | ANTIBODY, IMMUNE SYSTEM
4n9g:L (GLN3) to (ILE106) CRYSTAL STRUCTURE OF A COMPUTATIONALLY DESIGNED RSV-PRESENTING EPITOPE SCAFFOLD AND ITS ELICITED ANTIBODY 17HD9 | ANTIBODY, HAIRPIN, EPITOPE SCAFFOLD, IMMUNE SYSTEM
2jju:A (GLU3) to (VAL114) STRUCTURE OF HUMAN SIGNAL REGULATORY PROTEIN (SIRP) BETA | IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN SUPERFAMILY, SIGNAL REGULATORY PROTEIN BETA, IMMUNE SYSTEM, TRANSMEMBRANE, PAIRED RECEPTOR, ALTERNATIVE SPLICING, SIRP, SIRPB1, MEMBRANE, POLYMORPHISM, GLYCOPROTEIN
2jjw:A (MET6) to (LEU114) STRUCTURE OF HUMAN SIGNAL REGULATORY PROTEIN (SIRP) GAMMA | IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN SUPERFAMILY, SIRP, SIRPG, MEMBRANE, GLYCOPROTEIN, CELL ADHESION, SIGNAL REGULATORY PROTEIN GAMMA, TRANSMEMBRANE, PAIRED RECEPTOR, ALTERNATIVE SPLICING
2y07:L (GLN1) to (LEU109) CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-(4-HYDROXY-3- NITROPHENYL) -ACETYL MURINE GERMLINE MONOCLONAL ANTIBODY BBE6.12H3 FAB FRAGMENT IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE PPYPAWHAPGNI | IMMUNE SYSTEM, BETA-SANDWICH IMMUNOGLOBULIN FOLD, ANTIGEN BINDING, SECRETED PROTEIN
4ngh:L (GLU1) to (VAL106) CRYSTAL STRUCTURE OF THE HIV-1 NEUTRALIZING ANTIBODY 4E10 FAB FRAGMENT IN COMPLEX WITH A HYDROCARBON-STAPLED PEPTIDE CONTAINING THE 4E10 EPITOPE ON GP41 AND A TETHERED PHOSPHATE MOIETY. | IMMUNOGLOBULIN FOLD, BETA-SANDWICH, 4E10 FAB, ANTIBODY-EPITOPE COMPLEX, GP41 HIV-1, HYDROCARBON STAPLE, IMMUNE SYSTEM
4nhh:L (VAL2) to (ILE106) STRUCTURE OF 2G12 IGG DIMER | IG, ANTIBODY, IMMUNE SYSTEM
4nhh:G (VAL2) to (ILE106) STRUCTURE OF 2G12 IGG DIMER | IG, ANTIBODY, IMMUNE SYSTEM
4nhh:Q (VAL2) to (ILE106) STRUCTURE OF 2G12 IGG DIMER | IG, ANTIBODY, IMMUNE SYSTEM
1kcs:L (ASP1) to (LEU106) CRYSTAL STRUCTURE OF ANTIBODY PC282 IN COMPLEX WITH PS1 PEPTIDE | ANTIBODY, PEPTIDE ANTIGEN COMPLEX (ANTIBODY/PEPTIDE), IMMUNE SYSTEM
5c0r:L (ILE2) to (ILE106) CRYSTAL STRUCTURE OF A GENERATION 3 INFLUENZA HEMAGGLUTININ STABILIZED STEM COMPLEXED WITH THE BROADLY NEUTRALIZING ANTIBODY C179 | HEMAGGLUTININ, IMMUNOGEN, TRIMER, COMPLEX, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
1ken:U (ILE2) to (ILE107) INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH AN ANTIBODY THAT PREVENTS THE HEMAGGLUTININ LOW PH FUSOGENIC TRANSITION | HEMAGGLUTININ, ENVELOPE PROTEIN, GLYCOPROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
1wt5:C (ILE2) to (ILE111) THE CRYSTAL STRUCTURE OF A HUMANIZED ANTIBODY FV 528 | HUMANIZED ANTIBODY, IMMUNE SYSTEM
1wt5:D (ILE2) to (ILE111) THE CRYSTAL STRUCTURE OF A HUMANIZED ANTIBODY FV 528 | HUMANIZED ANTIBODY, IMMUNE SYSTEM
4np4:L (GLU1) to (ILE107) CLOSTRIDIUM DIFFICILE TOXIN B CROP DOMAIN IN COMPLEX WITH FAB DOMAINS OF NEUTRALIZING ANTIBODY BEZLOTOXUMAB | BEZLOTOXUMAB, HUMAN ANTIBODY, FAB, CROP DOMAIN, CYTOTOXIN, SHORT REPEAT, LONG REPEAT, TCDB, RECEPTOR BINDING, IMMUNE SYSTEM
4np4:M (GLU1) to (ILE107) CLOSTRIDIUM DIFFICILE TOXIN B CROP DOMAIN IN COMPLEX WITH FAB DOMAINS OF NEUTRALIZING ANTIBODY BEZLOTOXUMAB | BEZLOTOXUMAB, HUMAN ANTIBODY, FAB, CROP DOMAIN, CYTOTOXIN, SHORT REPEAT, LONG REPEAT, TCDB, RECEPTOR BINDING, IMMUNE SYSTEM
2mmx:A (ASN1) to (VAL110) NMR STUDY OF 6AJL2 | LIGHT CHAIN, AMYLOIDOSIS, SYSTEMIC, LAMBDA, IMMUNE SYSTEM
1xf4:L (LEU2) to (LEU106) STRUCTURE OF LIGAND-FREE FAB DNA-1 IN SPACE GROUP P321 SOLVED FROM CRYSTALS WITH PERFECT HEMIHEDRAL TWINNING | ANTIBODY, FAB, IMMUNOGLOBULIN, ANTI-DNA, ANTI-SSDNA, AUTOANTIBODY, TWINNING, IMMUNE SYSTEM
1xf3:L (LEU2) to (LEU106) STRUCTURE OF LIGAND-FREE FAB DNA-1 IN SPACE GROUP P65 | ANTIBODY, FAB, IMMUNOGLOBULIN, ANTI-DNA, ANTI-SSDNA, AUTOANTIBODY, IMMUNE SYSTEM
1xf3:A (LEU2) to (LEU106) STRUCTURE OF LIGAND-FREE FAB DNA-1 IN SPACE GROUP P65 | ANTIBODY, FAB, IMMUNOGLOBULIN, ANTI-DNA, ANTI-SSDNA, AUTOANTIBODY, IMMUNE SYSTEM
43c9:A (VAL3) to (LYS107) CRYSTALLOGRAPHIC STRUCTURE OF THE ESTEROLYTIC AND AMIDOLYTIC 43C9 ANTIBODY | IMMUNOGLOBULIN
43c9:C (VAL3) to (LYS107) CRYSTALLOGRAPHIC STRUCTURE OF THE ESTEROLYTIC AND AMIDOLYTIC 43C9 ANTIBODY | IMMUNOGLOBULIN
43c9:G (VAL3) to (LYS107) CRYSTALLOGRAPHIC STRUCTURE OF THE ESTEROLYTIC AND AMIDOLYTIC 43C9 ANTIBODY | IMMUNOGLOBULIN
5cd3:F (ILE2) to (ILE108) STRUCTURE OF IMMATURE VRC01-CLASS ANTIBODY DRVIA7 | VRC01, HIV-1, CD4 BINDING SITE, GP120, IMMUNE SYSTEM
1xgr:A (ILE2) to (ILE106) STRUCTURE FOR ANTIBODY HYHEL-63 Y33I MUTANT COMPLEXED WITH HEN EGG LYSOZYME | HYHEL-63, 2.1A CRYSTAL STRUCTURE, Y33I MUTANT, IMMUNE SYSTEM
1l7t:L (ASP1) to (ILE111) CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-TESTOSTERONE FAB FRAGMENT | ANTI-TESTOSTERONE, FAB FRAGMENT, AFFINITY AND SPECIFICITY MATURED, IMMUNE SYSTEM
3jwd:L (ILE2) to (ILE106) STRUCTURE OF HIV-1 GP120 WITH GP41-INTERACTIVE REGION: LAYERED ARCHITECTURE AND BASIS OF CONFORMATIONAL MOBILITY | HIV-1 VIRAL SPIKE, MOLECULAR MOTION, PROTEIN ARCHITECTURE, RECEPTOR- TRIGGERED ENTRY, TYPE 1 FUSION PROTEIN, CELL MEMBRANE, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, VIRAL PROTEIN
4oaw:A (ASP1) to (ILE106) FAB STRUCTURE OF ANTI-HIV GP120 V2 MAB 2158 | IG, ANTIBODY, HIV-1 GP120, IMMUNE SYSTEM
4ob5:L (VAL3) to (ILE106) ONTOGENY OF RECOGNITION SPECIFICITY AND FUNCTIONALITY FOR THE BROADLY NEUTRALIZING ANTI-HIV ANTIBODY 4E10 | IMMUNOGLOBULIN FOLD, ANTI-HIV ANTIBODY GERMLINE PRECURSOR, HIV GP41, IMMUNE SYSTEM
2ny0:C (ASP2001) to (ILE2108) HIV-1 GP120 ENVELOPE GLYCOPROTEIN (M95W, W96C, T257S, V275C, S334A, S375W, A433M) COMPLEXED WITH CD4 AND ANTIBODY 17B | HIV, GP120, ANTIBODY, CD4, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
2ny5:L (ASP2001) to (ILE2108) HIV-1 GP120 ENVELOPE GLYCOPROTEIN (M95W, W96C, I109C, T257S, V275C, S334A, S375W, Q428C, A433M) COMPLEXED WITH CD4 AND ANTIBODY 17B | HIV, GP120, ANTIBODY, CD4, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
2ny6:C (ASP2001) to (ILE2108) HIV-1 GP120 ENVELOPE GLYCOPROTEIN (M95W, W96C, I109C, T123C, T257S, V275C,S334A, S375W, Q428C, G431C) COMPLEXED WITH CD4 AND ANTIBODY 17B | HIV, GP120, ANTIBODY, CD4, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
2ny7:L (GLU1) to (ARG106) HIV-1 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH THE BROADLY NEUTRALIZING CD4-BINDING-SITE ANTIBODY B12 | HIV, GP120, BROADLY NEUTRALIZING ANTIBODY, B12, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
5cjo:L (MET5) to (ILE108) CRYSTAL STRUCTURE ANALYSIS OF ELBOW-ENGINEERED-FAB-BOUND HUMAN INSULIN DEGRADING ENZYME (IDE) IN COMPLEX WITH INSULIN | HYDROLASE, FAB, ELBOW-ENGINEER, HYDROLASE-HYDROLASE INHIBITOR COMPLEX
4ogx:L (ASP1) to (ILE105) CRYSTAL STRUCTURE OF FAB DX-2930 IN COMPLEX WITH HUMAN PLASMA KALLIKREIN AT 2.4 ANGSTROM RESOLUTION | FAB, ANTIBODY, KALLIKREIN, BLOOD, PLASMA, PLASMA KALLIKREIN- MEDIATED EDEMA, ACUTE HEREDITARY ANGIOEDEMA, HAE, HMWK, SERPIN C1-INHIBITOR, C1-INH, HEREDITARY ANGIOEDEMA, HAW, BRADYKININ, FLETCHER FACTOR, KININOGENIN, SERINE PROTEASE, EDEMA, HYDROLASE-ANTIBODY COMPLEX
1lmk:C (ILE202) to (LEU311) THE STRUCTURE OF A BIVALENT DIABODY | IMMUNOGLOBULIN, DIABODY, SINGLE-CHAIN FV, SCFV
5cp7:A (ASP1) to (ILE111) CRYSTAL STRUCTURE OF AN ANTIGEN-BINDING FRAGMENT OF MONOCLONAL ANTIBODY AGAINST SULFONAMIDES | ANTIGEN-BINDING FRAGMENT, ANTI-SULFONAMIDES ANTIBODY, IMMUNE SYSTEM
5cp7:G (VAL2) to (ILE111) CRYSTAL STRUCTURE OF AN ANTIGEN-BINDING FRAGMENT OF MONOCLONAL ANTIBODY AGAINST SULFONAMIDES | ANTIGEN-BINDING FRAGMENT, ANTI-SULFONAMIDES ANTIBODY, IMMUNE SYSTEM
4onf:L (VAL3) to (ILE111) FAB FRAGMENT OF 3D6 IN COMPLEX WITH AMYLOID BETA 1-7 | ANTIBODY, AMYLOID BETA PEPTIDE, IMMUNE SYSTEM
1mf2:L (VAL3) to (ILE106) ANTI HIV1 PROTEASE FAB COMPLEX | FAB FRAGMENT, CROSS-REACTIVITY, HIV1 PROTEASE, ENZYME INHIBITION, IMMUNOGLOBULIN
1mim:L (VAL3) to (ILE103) IGG FAB FRAGMENT (CD25-BINDING) | IMMUNOGLOBULIN, C REGION
5d1q:D (GLU1) to (ILE106) ISDB NEAT2 BOUND BY CLONE D2-06 | ISDB NEAT2, IGVH1-69, GERMLINE ENCODED, IMMUNE SYSTEM
5d1z:A (GLN5) to (ILE108) ISDB NEAT1 BOUND BY CLONE D4-10 | ISDB, NEAT1, GERMLINE ENCODED, IMMUNE SYSTEM
1mqk:L (ILE2) to (ILE107) CRYSTAL STRUCTURE OF THE UNLIGANDED FV-FRAGMENT OF THE ANTI- CYTOCHROME C OXIDASE ANTIBODY 7E2 | ANTIBODY, MEMBRANE PROTEIN, CYTOCHROME C OXIDASE, HIGH- RESOLUTION STRUCTURE, IMMUNE SYSTEM
5d8j:L (GLU1) to (LEU107) DEVELOPMENT OF A THERAPEUTIC MONOCLONAL ANTIBODY TARGETING SECRETED AP2 TO TREAT TYPE 2 DIABETES. | AP2, FABP4, DIABETES, METABOLIC SYNDROME, IMMUNE SYSTEM
3a6b:L (ILE2) to (ILE106) CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT LN32D COMPLEXED WITH HEN EGG WHITE LYSOZYME | ANTIGEN-ANTIBODY COMPLEX, MUTANT, IMMUNE SYSTEM-HYDROLASE COMPLEX, ALLERGEN, ANTIMICROBIAL, BACTERIOLYTIC ENZYME, DISULFIDE BOND, GLYCOSIDASE
3a6c:L (ILE2) to (ILE106) CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT LN92D COMPLEXED WITH HEN EGG WHITE LYSOZYME | ANTIGEN-ANTIBODY COMPLEX, MUTANT, IMMUNE SYSTEM-HYDROLASE COMPLEX, ALLERGEN, ANTIMICROBIAL, BACTERIOLYTIC ENZYME, DISULFIDE BOND, GLYCOSIDASE
3ab0:F (GLN2) to (GLU105) CRYSTAL STRUCTURE OF COMPLEX OF THE BACILLUS ANTHRACIS MAJOR SPORE SURFACE PROTEIN BCLA WITH SCFV ANTIBODY FRAGMENT | EXOSPORIUM, ANTHRAX, TBCLA, SCFV COMPLEX, IMMUNE SYSTEM
5dd0:L (ILE2) to (ILE106) CRYSTAL STRUCTURES IN AN ANTI-HIV ANTIBODY LINEAGE FROM IMMUNIZATION OF RHESUS MACAQUES | HIV HIV-1 GP41 MPER ANTIBODY, IMMUNE SYSTEM
5dd3:L (ILE2) to (ILE106) CRYSTAL STRUCTURES IN AN ANTI-HIV ANTIBODY LINEAGE FROM IMMUNIZATION OF RHESUS MACAQUES | HIV HIV-1 GP41 MPER ANTIBODY, IMMUNE SYSTEM
5dd5:L (ASP1) to (PHE106) CRYSTAL STRUCTURES IN AN ANTI-HIV ANTIBODY LINEAGE FROM IMMUNIZATION OF RHESUS MACAQUES | HIV HIV-1 GP41 MPER ANTIBODY, IMMUNE SYSTEM
3kym:A (ASP1) to (ILE106) CRYSTAL STRUCTURE OF LI33 IGG2 DI-FAB | IGG2 MONOCLONAL ANTI-LINGO, IMMUNE SYSTEM
3kym:E (GLN3) to (ILE106) CRYSTAL STRUCTURE OF LI33 IGG2 DI-FAB | IGG2 MONOCLONAL ANTI-LINGO, IMMUNE SYSTEM
3kym:K (ASP1) to (ILE106) CRYSTAL STRUCTURE OF LI33 IGG2 DI-FAB | IGG2 MONOCLONAL ANTI-LINGO, IMMUNE SYSTEM
3kym:M (ILE2) to (ILE106) CRYSTAL STRUCTURE OF LI33 IGG2 DI-FAB | IGG2 MONOCLONAL ANTI-LINGO, IMMUNE SYSTEM
1ynk:L (GLU1) to (GLU105) IDENTIFICATION OF KEY RESIDUES OF THE NC6.8 FAB ANTIBODY FRAGMENT BINDING TO SYNTHETIC SWEETENERS: CRYSTAL STRUCTURE OF NC6.8 CO-CRYSTALIZED WITH HIGH POTENCY SWEETENER COMPOUND SC45647 | SWEETENER COMPOUND, SC45657 AND NC174, IMMUNE SYSTEM
5dk3:F (GLU1) to (ILE110) CRYSTAL STRUCTURE OF PEMBROLIZUMAB, A FULL LENGTH IGG4 ANTIBODY | CANCER, ANTIBODY, SUBCLASSES, IGG4, MELANOMA, IMMUNE SYSTEM
3l5w:L (ASP1) to (ILE106) CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN IL-13 AND C836 FAB | IMMUNOGLOBULIN FOLD, ALPHA-HELICAL BUNDLE, CYTOKINE, DISULFIDE BOND, GLYCOPROTEIN, POLYMORPHISM, SECRETED, MONOCLONAL ANTIBODY, IMMUNE SYSTEM
1yyl:Q (ASP1001) to (ILE1106) CRYSTAL STRUCTURE OF CD4M33, A SCORPION-TOXIN MIMIC OF CD4, IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B | HIV-1, GP120, YU2, SCORPION TOXIN, CD4 MIMIC, CD4M33, ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
1yym:L (VAL3) to (ILE106) CRYSTAL STRUCTURE OF F23, A SCORPION-TOXIN MIMIC OF CD4, IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B | HIV-1, GP120, YU2, SCORPION TOXIN, CD4 MIMIC, F23, ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
5dmg:F (VAL503) to (VAL809) X-RAY STRUCTURE OF THE FAB FRAGMENT OF THE ANTI TAU ANTIBODY RB86 IN COMPLEX WITH THE PHOSPHORYLATED TAU PEPTIDE (416-430) | ANTIBODY, FAB FRAGMENT, TAU PROTEIN, TAU-PSER422, TAU-PSER422 COMPLEX, IMMUNE SYSTEM
3ley:L (VAL2) to (ILE111) 2F5 EPITOPE SCAFFOLD ELICITED ANTI-HIV-1 MONOCLONAL ANTIBODY 6A7 IN COMPLEX WITH HIV-1 GP41 | HIV-1, GP-41, MONOCLONAL ANTIBODY, 2F5, SCAFFOLD, EPITOPE, TRANSPLANT, GRAFT, RE-ELCITATION, ENVELOPE PROTEIN, IMMUNE SYSTEM, VACCINE DESIGN
4ptt:A (GLU1) to (ILE106) CRYSTAL STRUCTURE OF ANTI-23F STREP FAB C05 | ANTIBODY, FAB FRAGMENT, 23F, RHAMNOSE, IMMUNE SYSTEM
4ptu:A (ILE2) to (ILE106) CRYSTAL STRUCTURE OF ANTI-23F STREP FAB C05 WITH RHAMNOSE | ANTIBODY, FAB FRAGMENT, 23F, RHAMNOSE, IMMUNE SYSTEM
3liz:L (ILE2) to (ALA109) CRYSTAL STRUCTURE OF BLA G 2 COMPLEXED WITH FAB 4C3 | HYDROLASE-IMMUNE SYSTEM COMPLEX
1zlv:L (VAL3) to (ILE106) FAB 2G12 + MAN7 | HIV NEUTRALIZING ANTIBODY; ANTI-CARBOHYDRATE; DOMAIN- SWAPPING, IMMUNE SYSTEM
1zlw:K (VAL2) to (ILE106) FAB 2G12 + MAN8 | HIV NEUTRALIZING ANTIBODY; ANTI-CARBOHYDRATE; DOMAIN- SWAPPING, IMMUNE SYSTEM
5e2t:L (ASP1) to (VAL111) CRYSTAL STRUCTURE OF ANTI-TAU ANTIBODY AT8 FAB | IMMUNE SYSTEM
3auv:A (ASP12) to (ILE117) PREDICTING AMINO ACID PREFERENCES IN THE COMPLEMENTARITY DETERMINING REGIONS OF AN ANTIBODY-ANTIGEN RECOGNITION INTERFACE | SC-DSFV (DISULFIDE-STABILIZED SCFV), SCFV, MONOVALENT ANTIBODY, VEGF, ANTIBODY ENGINEERING, IMMUNE SYSTEM
3auv:B (GLN14) to (ILE117) PREDICTING AMINO ACID PREFERENCES IN THE COMPLEMENTARITY DETERMINING REGIONS OF AN ANTIBODY-ANTIGEN RECOGNITION INTERFACE | SC-DSFV (DISULFIDE-STABILIZED SCFV), SCFV, MONOVALENT ANTIBODY, VEGF, ANTIBODY ENGINEERING, IMMUNE SYSTEM
3auv:D (GLN14) to (ILE117) PREDICTING AMINO ACID PREFERENCES IN THE COMPLEMENTARITY DETERMINING REGIONS OF AN ANTIBODY-ANTIGEN RECOGNITION INTERFACE | SC-DSFV (DISULFIDE-STABILIZED SCFV), SCFV, MONOVALENT ANTIBODY, VEGF, ANTIBODY ENGINEERING, IMMUNE SYSTEM
3auv:F (GLN14) to (ILE117) PREDICTING AMINO ACID PREFERENCES IN THE COMPLEMENTARITY DETERMINING REGIONS OF AN ANTIBODY-ANTIGEN RECOGNITION INTERFACE | SC-DSFV (DISULFIDE-STABILIZED SCFV), SCFV, MONOVALENT ANTIBODY, VEGF, ANTIBODY ENGINEERING, IMMUNE SYSTEM
2a0l:E (VAL3) to (GLU105) CRYSTAL STRUCTURE OF KVAP-33H1 FV COMPLEX | VOLTAGE SENSOR, VOLTAGE-DEPENDENT K+ CHANNEL, K+ CHANNEL-FV COMPLEX, MEMBRANE PROTEIN, ION CHANNEL
5e8e:A (VAL3) to (ILE107) CRYSTAL STRUCTURE OF THROMBIN BOUND TO AN EXOSITE 1-SPECIFIC IGA FAB | IMMUNE SYSTEM-HYDROLASE COMPLEX, IMMUNE SYSTEM, INHIBITOR
2a77:L (LEU3) to (SER111) ANTI-COCAINE ANTIBODY 7.5.21, CRYSTAL FORM II | IMMUNE SYSTEM
3mck:L (VAL2) to (LEU111) CRYSTAL STRUCTURE OF ANTI-BETA-AMYLOID ANTIBODY C705 | IMMUNOGLOBULIN FOLD, MONOCLONAL ANTIBODY, IMMUNE SYSTEM
5esv:L (GLU1) to (LEU106) CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH03, ISOLATED FROM DONOR CH0219, IN COMPLEX WITH SCAFFOLDED TRIMERIC HIV-1 ENV V1V2 DOMAIN FROM THE CLADE C SUPERINFECTING STRAIN OF DONOR CAP256. | HIV-1, ENV, V1V2, CH0219, CHAVI, SCAFFOLD, CAP256, IMMUNE SYSTEM
3bkc:L (ASP1) to (LEU106) CRYSTAL STRUCTURE OF ANTI-AMYLOID BETA FAB WO2 (P21, FORMB) | ABETA, AMYLOID BETA PEPTIDE, FAB, WO2, ALZHEIMER'S DISEASE, IMMUNOTHERAPIES, APP, IMMUNE SYSTEM
5f3h:H (ASP1) to (ILE106) STRUCTURE OF MYOSTATIN IN COMPLEX WITH HUMANIZED RK35 ANTIBODY | MYOSTATIN, ANTIBODY, COMPLEX, SIGNALING PROTEIN-IMMUNE SYSTEM COMPLEX
3bsz:L (ILE2) to (ILE110) CRYSTAL STRUCTURE OF THE TRANSTHYRETIN-RETINOL BINDING PROTEIN-FAB COMPLEX | RETINOL, VITAMIN A, PROTEIN-PROTEIN COMPLEX, RBP, TTR, AMYLOID, DISEASE MUTATION, GLYCOPROTEIN, HORMONE, POLYNEUROPATHY, RETINOL- BINDING, SECRETED, THYROID HORMONE, TRANSPORT, SENSORY TRANSDUCTION, VISION, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX
5f96:L (ILE2) to (ILE106) CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING VH1-46 GERMLINE-DERIVED CD4- BINDING SITE-DIRECTED ANTIBODY CH235.12 IN COMPLEX WITH HIV-1 CLADE A/E 93TH057 GP120 | HIV-1, ANTIBODY, CH235 LINEAGE, VH1-46 GERMLINE, IMMUNE SYSTEM
5f9o:L (ILE2) to (ILE105) CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING VH1-46 GERMLINE-DERIVED CD4- BINDING SITE-DIRECTED ANTIBODY CH235.09 IN COMPLEX WITH HIV-1 CLADE A/E 93TH057 GP120 | ANTIBODY EVOLUTION HIV-1 BROADLY NEUTRALIZING CD4 BINDING SITE, IMMUNE SYSTEM
4r4n:L (ASP1) to (ILE106) CRYSTAL STRUCTURE OF THE ANTI-HIV-1 ANTIBODY 2.2C IN COMPLEX WITH HIV- 1 93UG037 GP120 | HIV-1 ATTACHMENT GLYCOPROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM-INHIBITOR COMPLEX
5fhx:L (ASP1) to (ILE110) CRYSTAL STRUCTURE OF CODV IN COMPLEX WITH IL4 AT 2.55 ANG. RESOLUTION. | CROSS-OVER DUAL VARIABLE IMMUNOGLOBULIN MULTIFUNCTIONAL BIOTHERAPEUTIC DRUG, CODV, IMMUNE SYSTEM
3na9:L (GLN3) to (ILE106) CRYSTAL STRUCTURE OF FAB15 | ANTIBODY, ANTIBODY CANONICAL STRUCTURE, THERMAL STABILITY, NON-X-PRO CIS PEPTIDE BOND, ANTIBODY ENGINEERING, IMMUNE SYSTEM
3nac:L (GLN3) to (ILE106) CRYSTAL STRUCTURE OF FAB15 MUT7 | ANTIBODY, ANTIBODY CANONICAL STRUCTURE, THERMAL STABILITY, NON-X-PRO CIS PEPTIDE BOND, ANTIBODY ENGINEERING, IMMUNE SYSTEM
3cdf:A (ILE2) to (ILE106) KI O18/O8 Y87H IMMUNOGLOBULIN LIGHT CHAIN VARIABLE DOMAIN | GREEK KEY BETA BARREL, AMYLOID, IMMUNOGLOBULIN, LIGHT CHAIN, VARIABLE DOMAIN, IMMUNE SYSTEM
3cdf:C (ILE2) to (ILE106) KI O18/O8 Y87H IMMUNOGLOBULIN LIGHT CHAIN VARIABLE DOMAIN | GREEK KEY BETA BARREL, AMYLOID, IMMUNOGLOBULIN, LIGHT CHAIN, VARIABLE DOMAIN, IMMUNE SYSTEM
3cdf:E (ILE2) to (ILE106) KI O18/O8 Y87H IMMUNOGLOBULIN LIGHT CHAIN VARIABLE DOMAIN | GREEK KEY BETA BARREL, AMYLOID, IMMUNOGLOBULIN, LIGHT CHAIN, VARIABLE DOMAIN, IMMUNE SYSTEM
4rbp:L (VAL3) to (ILE106) CRYSTAL STRUCTURE OF HIV NEUTRALIZING ANTIBODY 2G12 IN COMPLEX WITH A BACTERIAL OLIGOSACCHARIDE ANALOG OF MAMMALIAN OLIGOMANOSE | IMMUNOGLOBULIN FOLD, HIV NEUTRALIZING, HIV-1 GP120, IMMUNE SYSTEM
4rbp:K (VAL3) to (ILE106) CRYSTAL STRUCTURE OF HIV NEUTRALIZING ANTIBODY 2G12 IN COMPLEX WITH A BACTERIAL OLIGOSACCHARIDE ANALOG OF MAMMALIAN OLIGOMANOSE | IMMUNOGLOBULIN FOLD, HIV NEUTRALIZING, HIV-1 GP120, IMMUNE SYSTEM
4rdq:F (ILE2) to (VAL106) CALCIUM-ACTIVATED CHLORIDE CHANNEL BESTROPHIN-1, FROM CHICKEN, IN COMPLEX WITH FAB ANTIBODY FRAGMENTS, CHLORIDE AND CALCIUM | TRANSMEMBRANE PROTEIN, MEMBRANE PROTEIN, ION CHANNEL, CALCIUM- ACTIVATED CHLORIDE CHANNEL, CACC, ANION CHANNEL, MEMBRANE, TRANSPORT PROTEIN
4rdq:H (ILE2) to (VAL106) CALCIUM-ACTIVATED CHLORIDE CHANNEL BESTROPHIN-1, FROM CHICKEN, IN COMPLEX WITH FAB ANTIBODY FRAGMENTS, CHLORIDE AND CALCIUM | TRANSMEMBRANE PROTEIN, MEMBRANE PROTEIN, ION CHANNEL, CALCIUM- ACTIVATED CHLORIDE CHANNEL, CACC, ANION CHANNEL, MEMBRANE, TRANSPORT PROTEIN
4rdq:J (ILE2) to (VAL106) CALCIUM-ACTIVATED CHLORIDE CHANNEL BESTROPHIN-1, FROM CHICKEN, IN COMPLEX WITH FAB ANTIBODY FRAGMENTS, CHLORIDE AND CALCIUM | TRANSMEMBRANE PROTEIN, MEMBRANE PROTEIN, ION CHANNEL, CALCIUM- ACTIVATED CHLORIDE CHANNEL, CACC, ANION CHANNEL, MEMBRANE, TRANSPORT PROTEIN
4rdq:L (ILE2) to (VAL106) CALCIUM-ACTIVATED CHLORIDE CHANNEL BESTROPHIN-1, FROM CHICKEN, IN COMPLEX WITH FAB ANTIBODY FRAGMENTS, CHLORIDE AND CALCIUM | TRANSMEMBRANE PROTEIN, MEMBRANE PROTEIN, ION CHANNEL, CALCIUM- ACTIVATED CHLORIDE CHANNEL, CACC, ANION CHANNEL, MEMBRANE, TRANSPORT PROTEIN
4rdq:N (GLN3) to (VAL106) CALCIUM-ACTIVATED CHLORIDE CHANNEL BESTROPHIN-1, FROM CHICKEN, IN COMPLEX WITH FAB ANTIBODY FRAGMENTS, CHLORIDE AND CALCIUM | TRANSMEMBRANE PROTEIN, MEMBRANE PROTEIN, ION CHANNEL, CALCIUM- ACTIVATED CHLORIDE CHANNEL, CACC, ANION CHANNEL, MEMBRANE, TRANSPORT PROTEIN
3ncj:L (GLN3) to (ILE106) CRYSTAL STRUCTURE OF FAB15 MUT8 | ANTIBODY, IMMUNE SYSTEM
3ncy:W (LEU2) to (ILE110) X-RAY CRYSTAL STRUCTURE OF AN ARGININE AGMATINE ANTIPORTER (ADIC) IN COMPLEX WITH A FAB FRAGMENT | MEMBRANE PROTEIN COMPLEX WITH FAB FRAGMENT, ARGININE AGMATINE ANTIPORTER, VIRTUAL PROTON PUMP, APC SUPERFAMILY, IMMUNE SYSTEM, TRANSPORT PROTEIN
3ncy:S (LEU2) to (ILE110) X-RAY CRYSTAL STRUCTURE OF AN ARGININE AGMATINE ANTIPORTER (ADIC) IN COMPLEX WITH A FAB FRAGMENT | MEMBRANE PROTEIN COMPLEX WITH FAB FRAGMENT, ARGININE AGMATINE ANTIPORTER, VIRTUAL PROTON PUMP, APC SUPERFAMILY, IMMUNE SYSTEM, TRANSPORT PROTEIN
3ngb:F (VAL3) to (VAL106) CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC01 IN COMPLEX WITH HIV-1 GP120 | HIV, GP120, ANTIBODY, VRC01, NEUTRALIZATION, VACCINE, ENVELOPE GLYCOPROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3cle:L (ASP1) to (LEU106) HIV NEUTRALIZING MONOCLONAL ANTIBODY YZ23 | HIV-1, MONOCLONAL ANTIBODY, IMMUNE SYSTEM
3clf:L (ASP1) to (LEU106) HIV NEUTRALIZING MONOCLONAL ANTIBODY YZ23 | HIV-1, MONOCLONAL ANTIBODY, IMMUNE SYSTEM
3nn8:E (ASP1) to (LEU111) CRYSTAL STRUCTURE OF ENGINEERED ANTIBODY FRAGMENT BASED ON 3D5 | BETA BARREL, ANTIBODY FRAGMENT, IMMUNOGLOBULIN, IMMUNE SYSTEM
4cad:G (ASP1) to (LEU106) MECHANISM OF FARNESYLATED CAAX PROTEIN PROCESSING BY THE INTEGRAL MEMBRANE PROTEASE RCE1 | PROTEIN BINDING, INTEGRAL MEMBRANE PROTEASE, MONOCLONAL ANTIBODY FAB FRAGMENT
4cad:J (ASP1) to (LEU106) MECHANISM OF FARNESYLATED CAAX PROTEIN PROCESSING BY THE INTEGRAL MEMBRANE PROTEASE RCE1 | PROTEIN BINDING, INTEGRAL MEMBRANE PROTEASE, MONOCLONAL ANTIBODY FAB FRAGMENT
3cvh:R (ILE1) to (LEU105) HOW TCR-LIKE ANTIBODY RECOGNIZES MHC-BOUND PEPTIDE | MHC, TCR, GLYCOPROTEIN, IMMUNE RESPONSE, MEMBRANE, MHC I, TRANSMEMBRANE, ALLERGEN, PHOSPHOPROTEIN, SECRETED, IMMUNOGLOBULIN DOMAIN, IMMUNE SYSTEM
3cvi:L (ILE1) to (LEU105) HOW TCR-LIKE ANTIBODY RECOGNIZES MHC-BOUND PEPTIDE | FAB, IMMUNE SYSTEM
4ckd:L (ILE2) to (ILE106) MODEL OF COMPLEX BETWEEN THE E.COLI ENZYME BETA-GALACTOSIDASE AND FOUR SINGLE CHAIN FV ANTIBODY DOMAINS SCFV13R4. | HYDROLASE-IMMUNE SYSTEM COMPLEX
4ckd:M (ILE2) to (ILE106) MODEL OF COMPLEX BETWEEN THE E.COLI ENZYME BETA-GALACTOSIDASE AND FOUR SINGLE CHAIN FV ANTIBODY DOMAINS SCFV13R4. | HYDROLASE-IMMUNE SYSTEM COMPLEX
4ckd:N (ILE2) to (ILE106) MODEL OF COMPLEX BETWEEN THE E.COLI ENZYME BETA-GALACTOSIDASE AND FOUR SINGLE CHAIN FV ANTIBODY DOMAINS SCFV13R4. | HYDROLASE-IMMUNE SYSTEM COMPLEX
4ckd:O (ILE2) to (ILE106) MODEL OF COMPLEX BETWEEN THE E.COLI ENZYME BETA-GALACTOSIDASE AND FOUR SINGLE CHAIN FV ANTIBODY DOMAINS SCFV13R4. | HYDROLASE-IMMUNE SYSTEM COMPLEX
3o0r:L (ASP1) to (LEU106) CRYSTAL STRUCTURE OF NITRIC OXIDE REDUCTASE FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH ANTIBODY FRAGMENT | OXIDOREDUCTASE, ELECTRON TRANSPORT, HEME, IRON, MEMBRANE, CYTOPLASMIC MEMBRANE, IMMUNE SYSTEM-OXIDOREDUCTASE COMPLEX
4rx4:L (ILE2) to (ARG106) CRYSTAL STRUCTURE OF VH1-46 GERMLINE-DERIVED CD4-BINDING SITE-DIRECTED ANTIBODY 8ANC134 IN COMPLEX WITH HIV-1 CLADE A Q842.D12 GP120 | HIV-1 ATTACHMENT PROTEIN, BROADLY NEUTRALIZING ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4rx4:D (ILE2) to (ARG106) CRYSTAL STRUCTURE OF VH1-46 GERMLINE-DERIVED CD4-BINDING SITE-DIRECTED ANTIBODY 8ANC134 IN COMPLEX WITH HIV-1 CLADE A Q842.D12 GP120 | HIV-1 ATTACHMENT PROTEIN, BROADLY NEUTRALIZING ANTIBODY, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4s2s:L (ILE2) to (ILE112) CRYSTAL STRUCTURE OF FAB FRAGMENT OF MONOCLONAL ANTIBODY ROAB13 | IMMUNOGLOBULIN, IMMUNE SYSTEM
4s2s:B (VAL3) to (ILE112) CRYSTAL STRUCTURE OF FAB FRAGMENT OF MONOCLONAL ANTIBODY ROAB13 | IMMUNOGLOBULIN, IMMUNE SYSTEM
3oay:K (ALA1) to (ILE106) A NON-SELF SUGAR MIMIC OF THE HIV GLYCAN SHIELD SHOWS ENHANCED ANTIGENICITY | FAB, IMMUNE SYSTEM
3oay:L (ALA1) to (ILE106) A NON-SELF SUGAR MIMIC OF THE HIV GLYCAN SHIELD SHOWS ENHANCED ANTIGENICITY | FAB, IMMUNE SYSTEM
3oaz:K (VAL3) to (ILE106) A NON-SELF SUGAR MIMIC OF THE HIV GLYCAN SHIELD SHOWS ENHANCED ANTIGENICITY | FAB, IMMUNE SYSTEM
3oaz:L (ALA1) to (ILE106) A NON-SELF SUGAR MIMIC OF THE HIV GLYCAN SHIELD SHOWS ENHANCED ANTIGENICITY | FAB, IMMUNE SYSTEM
3ob0:L (ALA1) to (ILE106) A NON-SELF SUGAR MIMIC OF THE HIV GLYCAN SHIELD SHOWS ENHANCED ANTIGENICITY | FAB, IMMUNE SYSTEM
3ob0:K (ALA1) to (ILE106) A NON-SELF SUGAR MIMIC OF THE HIV GLYCAN SHIELD SHOWS ENHANCED ANTIGENICITY | FAB, IMMUNE SYSTEM
5ggu:B (GLN3) to (ILE106) CRYSTAL STRUCTURE OF TREMELIMUMAB FAB | ANTIBODY, IMMUNE SYSTEM
5ggv:L (GLN3) to (ILE106) CTLA-4 IN COMPLEX WITH TREMELIMUMAB FAB | ANTIBODY, IMMUNE SYSTEM
5gis:L (ILE2) to (MET106) CRYSTAL STRUCTURE OF A FAB FRAGMENT WITH ITS LIGAND PEPTIDE | FAB, PEPTIDE LIGAND, MUTATION, IMMUNE SYSTEM
4tuj:D (VAL2) to (LEU112) CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY AGAINST NEUROBLASTOMA ASSOCIATED ANTIGEN. | ANTIBODY, NEUROBLASTOMA, IMMUNE SYSTEM
4tuk:L (VAL2) to (LEU112) CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY AGAINST NEUROBLASTOMA ASSOCIATED ANTIGEN. | IMMUNE SYSTEM, NEUROBLASTOMA
5grz:A (VAL126) to (ILE230) CRYSTAL STRUCTURE OF DISULFIDE-BONDED DIABODY | DIABODY, ANTIBODY FRAGMENT, DISULFIDE BOND, IMMUNE SYSTEM
3dmk:A (TYR105) to (GLU205) CRYSTAL STRUCTURE OF DOWN SYNDROME CELL ADHESION MOLECULE (DSCAM) ISOFORM 1.30.30, N-TERMINAL EIGHT IG DOMAINS | IG DOMAINS, IMMUNOGLOBULIN DOMAIN, CELL ADHESION
3dmk:B (TYR105) to (GLU205) CRYSTAL STRUCTURE OF DOWN SYNDROME CELL ADHESION MOLECULE (DSCAM) ISOFORM 1.30.30, N-TERMINAL EIGHT IG DOMAINS | IG DOMAINS, IMMUNOGLOBULIN DOMAIN, CELL ADHESION
3dmk:C (TYR105) to (GLU205) CRYSTAL STRUCTURE OF DOWN SYNDROME CELL ADHESION MOLECULE (DSCAM) ISOFORM 1.30.30, N-TERMINAL EIGHT IG DOMAINS | IG DOMAINS, IMMUNOGLOBULIN DOMAIN, CELL ADHESION
5gs3:H (ASP125) to (ILE230) CRYSTAL STRUCTURE OF DIABODY | DIABODY, ANTIBODY FRAGMENT, IMMUNE SYSTEM
4dgv:L (GLU1) to (ILE106) STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY HCV1, P2(1) FORM | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
3p0v:L (ASP1) to (ILE106) ANTI-EGFR/HER3 FAB DL11 ALONE | BETA-SANDWICH, IMMUNE SYSTEM, ANTIGENS EGFR AND HER3
3p0v:M (ASP1) to (ILE106) ANTI-EGFR/HER3 FAB DL11 ALONE | BETA-SANDWICH, IMMUNE SYSTEM, ANTIGENS EGFR AND HER3
5hj3:F (LEU2) to (ILE106) CRYSTAL STRUCTURE OF HOST-PRIMED EBOLA VIRUS GP, GPCL. | EBOLA VIRUS, EOV, EBOLAVIRUS, GP, GLYCOPROTEIN, GPCL, CLEAVED, PRIMED, PROTEOLYTICALLY, RECEPTOR BINDING POCKET, CREST, TROUGH, MR72, KZ52, BROADLY NEUTRALIZING, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
5hj3:N (GLU1) to (ILE106) CRYSTAL STRUCTURE OF HOST-PRIMED EBOLA VIRUS GP, GPCL. | EBOLA VIRUS, EOV, EBOLAVIRUS, GP, GLYCOPROTEIN, GPCL, CLEAVED, PRIMED, PROTEOLYTICALLY, RECEPTOR BINDING POCKET, CREST, TROUGH, MR72, KZ52, BROADLY NEUTRALIZING, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4u6h:D (VAL3) to (ILE111) VACCINIA L1/M12B9-FAB COMPLEX | IGG2A, FAB, HEAVY CHAIN LIGHT CHAIN
4u6v:L (GLN3) to (ILE105) MECHANISMS OF NEUTRALIZATION OF A HUMAN ANTI-ALPHA TOXIN ANTIBODY | ALPHA TOXIN, FAB, STAPHYLOCOCCUS AUREUS, MUTAGENESIS, IMMUNE SYSTEM
4u6v:M (GLN3) to (ILE105) MECHANISMS OF NEUTRALIZATION OF A HUMAN ANTI-ALPHA TOXIN ANTIBODY | ALPHA TOXIN, FAB, STAPHYLOCOCCUS AUREUS, MUTAGENESIS, IMMUNE SYSTEM
5i1l:A (VAL3) to (ILE112) CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV5-51/IGKV4-1 | MONOCLONAL ANTIBODY, IMMUNE SYSTEM
4dvr:L (ILE2) to (ILE105) CRYSTAL STRUCTURE OF YU2 GP120 CORE IN COMPLEX WITH FAB 48D AND NBD- 557 | HIV-1 GP120, CD4 BINDING SITE, NBD-557, IMMUNE SYSTEM-TRANSCRIPTION INHIBITOR COMPLEX
5i8h:F (ILE2) to (ILE106) CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH V3 LOOP-TARGETING ANTIBODY PGT122 FAB AND FUSION PEPTIDE-TARGETING ANTIBODY VRC34.01 FAB | HIV-1, ENVELOPE, TRIMER, FUSION PEPTIDE, ANTIBODY, NEUTRALIZING, IMMUNE SYSTEM
5i8h:H (ILE2) to (ILE106) CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH V3 LOOP-TARGETING ANTIBODY PGT122 FAB AND FUSION PEPTIDE-TARGETING ANTIBODY VRC34.01 FAB | HIV-1, ENVELOPE, TRIMER, FUSION PEPTIDE, ANTIBODY, NEUTRALIZING, IMMUNE SYSTEM
5ibu:B (GLU1) to (ILE107) 6652 FAB (UNBOUND) | ANTIBODY, INFLUENZA, UNBOUND, IMMUNE SYSTEM
4uta:L (SER0) to (ILE107) CRYSTAL STRUCTURE OF DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE1 C8 | IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX, VIRAL PROTEIN, MEMBRANE FUSION, CLASS 2 FUSION PROTEIN, DENGUE VIRUS, BROADLY NEUTRALIZING ANTIBODY
4uta:M (GLU1) to (ILE107) CRYSTAL STRUCTURE OF DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE1 C8 | IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX, VIRAL PROTEIN, MEMBRANE FUSION, CLASS 2 FUSION PROTEIN, DENGUE VIRUS, BROADLY NEUTRALIZING ANTIBODY
5ikc:A (ASP1) to (LEU106) X-RAY STRUCURE OF THE N-TERMINAL DOMAIN OF HUMAN DOUBLECORTIN IN COMPLEX WITH FAB | DCX DOMAIN, UBIQUITIN-LIKE FOLD, MICROTUBULE ASSOCIATED, SIGNALING PROTEIN, TRANSFERASE
5ikc:L (ASP1) to (LEU106) X-RAY STRUCURE OF THE N-TERMINAL DOMAIN OF HUMAN DOUBLECORTIN IN COMPLEX WITH FAB | DCX DOMAIN, UBIQUITIN-LIKE FOLD, MICROTUBULE ASSOCIATED, SIGNALING PROTEIN, TRANSFERASE
3q3g:A (ILE2) to (LEU112) CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY | IMMUNE SYSTEM-CELL ADHESION COMPLEX
3q3g:F (ILE2) to (LEU112) CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY | IMMUNE SYSTEM-CELL ADHESION COMPLEX
3q3g:J (ILE2) to (LEU112) CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY | IMMUNE SYSTEM-CELL ADHESION COMPLEX
3qeg:L (GLU1) to (ILE106) CRYSTAL STRUCTURE OF HUMAN N12-I2 FAB, AN ADCC AND NEUTRALIZING ANTI- HIV-1 ENV ANTIBODY | ADCC AND NEUTRALIZING ANTI-HIV-1 ENV ANTIBODY N12-I2, CD4I ANTIBODY, FAB FRAGMENT, BINDS TO VIRAL GLYCOPROTEIN GP120, IMMUNE SYSTEM
4f2m:B (ILE2) to (LEU106) CRYSTAL STRUCTURE OF A TGEV CORONAVIRUS SPIKE FRAGMENT IN COMPLEX WITH THE TGEV NEUTRALIZING MONOCLONAL ANTIBODY 1AF10 | BETA-BARREL, IMMUNOGLOBULIN, VIRUS ENTRY, VIRUS NEUTRALIZATION, CELLULAR RECEPTOR, AMINOPEPTIDASE N, GLYCOSYLATION, VIRUS MEMBRANE, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4fz8:L (ASP1) to (ILE106) CRYSTAL STRUCTURE OF C11 FAB, AN ADCC MEDIATING ANTI-HIV-1 ANTIBODY. | ADCC, ANTI-HIV-1 ENV ANTIBODY C11, CD4I ANTIBODY, FAB, VIRAL GLYCOPROTEIN GP120, HIV-1 ENV, IMMUNE SYSTEM
5k9j:L (VAL3) to (ILE106) CRYSTAL STRUCTURE OF MULTIDONOR HV6-1-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 56.A.09 ISOLATED FOLLOWING H5 IMMUNIZATION. | INFLUENZA, MULTIDONOR, H5, UNIVERSAL INFLUENZA VACCINE, IMMUNE SYSTEM
5k9q:I (ILE2) to (ILE106) CRYSTAL STRUCTURE OF MULTIDONOR HV1-18-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 16.A.26 IN COMPLEX WITH A/HONG KONG/1-4-MA21- 1/1968 (H3N2) HEMAGGLUTININ | HV1-18 (QXXV), MULTIDONOR, H5, UNIVERSAL INFLUENZA VACCINE, IMMUNE SYSTEM
5k9q:L (ILE2) to (ILE106) CRYSTAL STRUCTURE OF MULTIDONOR HV1-18-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 16.A.26 IN COMPLEX WITH A/HONG KONG/1-4-MA21- 1/1968 (H3N2) HEMAGGLUTININ | HV1-18 (QXXV), MULTIDONOR, H5, UNIVERSAL INFLUENZA VACCINE, IMMUNE SYSTEM
5k9q:T (ILE2) to (ILE106) CRYSTAL STRUCTURE OF MULTIDONOR HV1-18-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 16.A.26 IN COMPLEX WITH A/HONG KONG/1-4-MA21- 1/1968 (H3N2) HEMAGGLUTININ | HV1-18 (QXXV), MULTIDONOR, H5, UNIVERSAL INFLUENZA VACCINE, IMMUNE SYSTEM
5k9q:V (GLN3) to (ILE106) CRYSTAL STRUCTURE OF MULTIDONOR HV1-18-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 16.A.26 IN COMPLEX WITH A/HONG KONG/1-4-MA21- 1/1968 (H3N2) HEMAGGLUTININ | HV1-18 (QXXV), MULTIDONOR, H5, UNIVERSAL INFLUENZA VACCINE, IMMUNE SYSTEM
5k9q:Y (ILE2) to (ILE106) CRYSTAL STRUCTURE OF MULTIDONOR HV1-18-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 16.A.26 IN COMPLEX WITH A/HONG KONG/1-4-MA21- 1/1968 (H3N2) HEMAGGLUTININ | HV1-18 (QXXV), MULTIDONOR, H5, UNIVERSAL INFLUENZA VACCINE, IMMUNE SYSTEM
5kem:E (ASP1) to (LEU104) EBOV SGP IN COMPLEX WITH VARIABLE FAB DOMAINS OF IGGS C13C6 AND BDBV91 | EBOLA VIRUS SECRETED GLYCOPROTEIN, SGP, ANTIBODIES, VIRAL PROTEIN- IMMUNE SYSTEM COMPLEX
5kem:J (ASP1) to (LEU104) EBOV SGP IN COMPLEX WITH VARIABLE FAB DOMAINS OF IGGS C13C6 AND BDBV91 | EBOLA VIRUS SECRETED GLYCOPROTEIN, SGP, ANTIBODIES, VIRAL PROTEIN- IMMUNE SYSTEM COMPLEX
5ken:D (GLN3) to (ILE106) EBOV GP IN COMPLEX WITH VARIABLE FAB DOMAINS OF IGGS C4G7 AND C13C6 | EBOLA VIRUS SURFACE GLYCOPROTEIN, THERAPEUTIC ANTIBODY COCKTAIL, ZMAPP, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
5lbs:L (GLU1) to (ILE106) STRUCTURAL BASIS OF ZIKA AND DENGUE VIRUS POTENT ANTIBODY CROSS- NEUTRALIZATION | IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX, ZIKA VIRUS, BROADLY NEUTRALIZING ANTIBODY, IMMUNE SYSTEM-VIRAL PROTEIN
5lbs:M (ILE2) to (ILE106) STRUCTURAL BASIS OF ZIKA AND DENGUE VIRUS POTENT ANTIBODY CROSS- NEUTRALIZATION | IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX, ZIKA VIRUS, BROADLY NEUTRALIZING ANTIBODY, IMMUNE SYSTEM-VIRAL PROTEIN
5lve:A (ILE2) to (ILE106) STRUCTURE OF THE VARIABLE DOMAIN OF HUMAN IMMUNOGLOBULIN K-4 LIGHT CHAIN LEN | IMMUNOGLOBULIN, BENCE-JONES PROTEIN, IMMUNE SYSTEM
5tgb:L (ILE2) to (ILE108) STRUCTURE OF CHIMERIC 02-CB FAB, A VRC01-LIKE GERMLINE ANTIBODY | FAB, GERMLINE, VRC01-LIKE, CD4-BS, HIV-1, CDRH3, IMMUNE SYSTEM
5tgb:B (GLU1) to (ILE108) STRUCTURE OF CHIMERIC 02-CB FAB, A VRC01-LIKE GERMLINE ANTIBODY | FAB, GERMLINE, VRC01-LIKE, CD4-BS, HIV-1, CDRH3, IMMUNE SYSTEM
15c8:L (VAL3) to (ILE106) CATALYTIC ANTIBODY 5C8, FREE FAB | CATALYTIC ANTIBODY, FAB, RING CLOSURE REACTION
2ai0:M (LEU3) to (SER111) ANTI-COCAINE ANTIBODY 7.5.21, CRYSTAL FORM III | IMMUNE SYSTEM
2aj3:A (LEU2) to (ILE106) CRYSTAL STRUCTURE OF A CROSS-REACTIVE HIV-1 NEUTRALIZING CD4-BINDING SITE ANTIBODY FAB M18 | HIV, ANTIBODY, FAB, CD4-BINDING, IMMUNOGLOBULIN, IMMUNE SYSTEM
2aj3:C (LEU2) to (ILE106) CRYSTAL STRUCTURE OF A CROSS-REACTIVE HIV-1 NEUTRALIZING CD4-BINDING SITE ANTIBODY FAB M18 | HIV, ANTIBODY, FAB, CD4-BINDING, IMMUNOGLOBULIN, IMMUNE SYSTEM
2aj3:E (LEU2) to (ILE106) CRYSTAL STRUCTURE OF A CROSS-REACTIVE HIV-1 NEUTRALIZING CD4-BINDING SITE ANTIBODY FAB M18 | HIV, ANTIBODY, FAB, CD4-BINDING, IMMUNOGLOBULIN, IMMUNE SYSTEM
3ru8:L (GLU1) to (ARG107) STRUCTURE OF AN HIV EPITOPE SCAFFOLD IN COMPLEX WITH NEUTRALIZING ANTIBODY B12 FAB | BINDING EPITOPE FROM HIV ON A HETEROLOGOUS PROTEIN, IMMUNE SYSTEM, DE NOVO PROTEIN
3rvv:C (VAL3) to (MET106) CRYSTAL STRUCTURE OF DER F 1 COMPLEXED WITH FAB 4C1 | COMPLEX BETWEEN AN ALLERGEN AND FAB FRAGMENT OF 4C1 ANTIBODY, HYDROLASE-IMMUNE SYSTEM COMPLEX
1bm3:L (GLU2) to (ILE106) IMMUNOGLOBULIN OPG2 FAB-PEPTIDE COMPLEX | IMMUNOGLOBULIN, IMMUNE SYSTEM
3f7v:B (ILE2) to (ALA109) KCSA POTASSIUM CHANNEL IN THE OPEN-INACTIVATED STATE WITH 23 A OPENING AT T112 | KCSA, POTASSIUM CHANNEL, INACTIVATION, OPEN, CELL MEMBRANE, ION TRANSPORT, IONIC CHANNEL, MEMBRANE, TRANSMEMBRANE, TRANSPORT, VOLTAGE-GATED CHANNEL, MEMBRANE PROTEIN-METAL TRANSPORT COMPLEX
4x8x:A (GLN104) to (GLU205) CRYSTAL STRUCTURE OF DSCAM1 ISOFORM 1.9, N-TERMINAL FOUR IG DOMAINS | IG FOLD, CELL ADHESION
4x8x:B (TYR105) to (LEU201) CRYSTAL STRUCTURE OF DSCAM1 ISOFORM 1.9, N-TERMINAL FOUR IG DOMAINS | IG FOLD, CELL ADHESION
3fb5:B (ILE2) to (ALA109) KCSA POTASSIUM CHANNEL IN THE PARTIALLY OPEN STATE WITH 14.5 A OPENING AT T112 | KCSA, OPEN, INACTIVATION, POTASSIUM CHANNEL, CELL MEMBRANE, ION TRANSPORT, IONIC CHANNEL, MEMBRANE, TRANSMEMBRANE, TRANSPORT, VOLTAGE-GATED CHANNEL, MEMBRANE PROTEIN-METAL TRANSPORT COMPLEX
3fb7:B (ILE2) to (ALA109) OPEN KCSA POTASSIUM CHANNEL IN THE PRESENCE OF RB+ ION | KCSA, OPEN, INACTIVATION, POTASSIUM CHANNEL, CELL MEMBRANE, ION TRANSPORT, IONIC CHANNEL, MEMBRANE, TRANSMEMBRANE, TRANSPORT, VOLTAGE-GATED CHANNEL, MEMBRANE PROTEIN-METAL TRANSPORT COMPLEX
4xmp:L (GLY3) to (ILE106) CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC08 IN COMPLEX WITH HIV-1 CLADE A STRAIN Q842.D12 GP120 | ANTIBODY, HIV-1, IMMUNE SYSTEM
1dqm:L (ILE2) to (ILE106) CRYSTAL STRUCTURE OF ANTI-LYSOZYME ANTIBODY | ANTIBODY, HEN EGG WHITE LYSOZYME, IMMUNE SYSTEM
3gi8:L (ASP1) to (ILE112) CRYSTAL STRUCTURE OF APCT K158A TRANSPORTER BOUND TO 7F11 MONOCLONAL FAB FRAGMENT | MEMBRANE PROTEIN, TRANSPORTER, ANTIBODY, CELL MEMBRANE, MEMBRANE, TRANSMEMBRANE, TRANSPORT PROTEIN, STRUCTURAL GENOMICS, PSI-2, PROTEIN STRUCTURE INITIATIVE, NEW YORK CONSORTIUM ON MEMBRANE PROTEIN STRUCTURE, NYCOMPS
3giz:L (ILE2) to (ILE106) CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-CD20 ANTIBODY OFATUMUMAB | CD20, 2F2, OFATUMUMAB, HU-MAXCD20, FAB, ANTIBODY, FULLY HUMAN ANTIBODY, IMMUNE SYSTEM
2dqd:L (ILE2) to (ILE106) CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT (HY50F) COMPLEXED WITH HEN EGG LYSOZYME | ANTIGEN-ANTIBODY COMPLEX, MUTANT, IMMUNE SYSTEM/HYDROLASE COMPLEX
4ybq:E (ILE4) to (ILE113) RAT GLUT5 WITH FV IN THE OUTWARD-OPEN FORM | SUGAR TRANSPORTER, MAJOR FACILITATOR SUPERFAMILY, TRANSPORT PROTEIN- IMMUNE SYSTEM COMPLEX
3u46:B (GLU1) to (LEU106) CH04H/CH02L P212121 | IGG, IMMUNOGLOBLULIN, IMMUNE SYSTEM, HIV-1 ANTIBODIES, V1V2-DIRECTED
4yue:L (ILE5) to (LEU109) MOUSE IL-2 BOUND TO S4B6 FAB FRAGMENT | CHEMOKINE, ANTIBODY, COMPLEX, CYTOKINE/IMMUNE SYSTEM COMPLEX
4kmt:L (ASP1) to (VAL106) CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY 5-51/O12 | IMMUNOGLOBULIN FOLD, ANTIBODY, IMMUNE SYSTEM
4ky1:L (ILE2) to (ILE106) HUMANIZED HP1/2 FAB | FAB, ANTIBODY, ALPHA4 INTEGRIN, IMMUNE SYSTEM
3ve0:B (ASP1) to (LEU106) CRYSTAL STRUCTURE OF SUDAN EBOLAVIRUS GLYCOPROTEIN (STRAIN BONIFACE) BOUND TO 16F6 | EBOLA, SUDAN, GLYCOPROTEIN, VIRUS SURFACE, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
3iy0:L (ILE2) to (ILE106) VARIABLE DOMAINS OF THE X-RAY STRUCTURE OF FAB 14 FITTED INTO THE CRYOEM RECONSTRUCTION OF THE VIRUS-FAB 14 COMPLEX | CRYOEM, NEUTRALIZING ANTIBODY, PARVOVIRUS, CANINE, FELINE, FAB FOOTPRINT, IMMUNE SYSTEM
4lmq:I (GLN3) to (ILE106) DEVELOPMENT AND PRECLINICAL CHARACTERIZATION OF A HUMANIZED ANTIBODY TARGETING CXCL12 | IMMUNOGLOBULIN, CELL ADHESION-IMMUNE SYSTEM COMPLEX
4lvo:B (VAL3) to (LEU107) CRYSTAL STRUCTURE OF PFSUB1-PRODOMAIN-NIMP.M7 FAB COMPLEX WITH ADDED CACL2 | ALPHA BETA, ENZYME-PRODOMAIN COMPLEX, ROSSMANN FOLD, SERINE PROTEASE, CALCIUM IONS, PRODOMAIN, PARASITOPHOROUS VACUOLE, HYDROLASE- INHIBITOR-IMMUNE SYSTEM COMPLEX
1ua6:L (ILE2) to (ILE106) CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT SFSF COMPLEXED WITH HEN EGG WHITE LYSOZYME COMPLEX | ANTIGEN-ANTIBODY COMPLEX, HYHEL-10, MUTANT, ANTI-HEN EGG WHITE LYSOZYME ANTIBODY, IMMUNE SYSTEM/HYDROLASE COMPLEX
4m1c:F (MET4) to (THR110) CRYSTAL STRUCTURE ANALYSIS OF FAB-BOUND HUMAN INSULIN DEGRADING ENZYME (IDE) IN COMPLEX WITH AMYLOID-BETA (1-40) | HYDROLASE, ZINC METALLOPROTEASE
3wfb:L (GLN3) to (LEU106) REDUCED CYTOCHROME C-DEPENDENT NITRIC OXIDE REDUCTASE (CNOR) FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH ANTIBODY FRAGMENT | METAL-BINDING, MEMBRANE PROTEIN, IMMUNE SYSTEM-OXIDOREDUCTASE COMPLEX
2itd:B (ILE2) to (ALA109) POTASSIUM CHANNEL KCSA-FAB COMPLEX IN BARIUM CHLORIDE | VOLTAGE-GATED CHANNEL, TRANSMEMBRANE, IONIC CHANNEL, ION TRANSPORT, K CHANNEL, PROTEIN-ANTIBODY FAB COMPLEX, MEMBRANE PROTEIN
3j5m:C (VAL3) to (ILE106) CRYO-EM STRUCTURE OF THE BG505 SOSIP.664 HIV-1 ENV TRIMER WITH 3 PGV04 FABS | HIV-1 TRIMERIC SPIKE, GP140, SOSIP, BROADLY NEUTRALIZING ANTIBODY, PGV04, ENV, ENVELOPE GLYCOPROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3j5m:G (VAL3) to (ILE106) CRYO-EM STRUCTURE OF THE BG505 SOSIP.664 HIV-1 ENV TRIMER WITH 3 PGV04 FABS | HIV-1 TRIMERIC SPIKE, GP140, SOSIP, BROADLY NEUTRALIZING ANTIBODY, PGV04, ENV, ENVELOPE GLYCOPROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3j5m:K (VAL3) to (ILE106) CRYO-EM STRUCTURE OF THE BG505 SOSIP.664 HIV-1 ENV TRIMER WITH 3 PGV04 FABS | HIV-1 TRIMERIC SPIKE, GP140, SOSIP, BROADLY NEUTRALIZING ANTIBODY, PGV04, ENV, ENVELOPE GLYCOPROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4nko:E (ASP1) to (LEU111) CRYSTAL STRUCTURE OF ENGINEERED ANTI-EE SCFV ANTIBODY FRAGMENT | ANTIBODY FRAGMENT, HEXA-HISTIDINE BINDING, IMMUNE SYSTEM, IMMUNE SYSTEM-CHAPERONE COMPLEX
4nzu:L (GLU3) to (THR106) CRYSTAL STRUCTURE OF THE PRIMARY MONOCLONAL ANTIBODY 13PL FAB' FROM A MULTIPLE MYELOMA PATIENT | ANTIBODY FAB, MULTIPLE MYELOMA, PRIMARY ANTIBODY, IMMUNE SYSTEM
3juy:B (GLU143) to (ARG249) CRYSTAL STRUCTURE OF A 3B3 VARIANT, A BROADLY NEUTRALIZING HIV-1 SCFV ANTIBODY | HIV, ENVELOPE PROTEIN GP120, BROADLY NEUTRALIZING ANTIBODY, 3B3 SINGLE CHAIN VARIABLE FRAGMENT, IMMUNE SYSTEM
3juy:C (GLU143) to (ARG249) CRYSTAL STRUCTURE OF A 3B3 VARIANT, A BROADLY NEUTRALIZING HIV-1 SCFV ANTIBODY | HIV, ENVELOPE PROTEIN GP120, BROADLY NEUTRALIZING ANTIBODY, 3B3 SINGLE CHAIN VARIABLE FRAGMENT, IMMUNE SYSTEM
3juy:E (GLU143) to (ARG249) CRYSTAL STRUCTURE OF A 3B3 VARIANT, A BROADLY NEUTRALIZING HIV-1 SCFV ANTIBODY | HIV, ENVELOPE PROTEIN GP120, BROADLY NEUTRALIZING ANTIBODY, 3B3 SINGLE CHAIN VARIABLE FRAGMENT, IMMUNE SYSTEM
3juy:F (GLU143) to (ARG249) CRYSTAL STRUCTURE OF A 3B3 VARIANT, A BROADLY NEUTRALIZING HIV-1 SCFV ANTIBODY | HIV, ENVELOPE PROTEIN GP120, BROADLY NEUTRALIZING ANTIBODY, 3B3 SINGLE CHAIN VARIABLE FRAGMENT, IMMUNE SYSTEM
3juy:D (GLU143) to (ARG249) CRYSTAL STRUCTURE OF A 3B3 VARIANT, A BROADLY NEUTRALIZING HIV-1 SCFV ANTIBODY | HIV, ENVELOPE PROTEIN GP120, BROADLY NEUTRALIZING ANTIBODY, 3B3 SINGLE CHAIN VARIABLE FRAGMENT, IMMUNE SYSTEM
3jwo:L (ILE2) to (ILE106) STRUCTURE OF HIV-1 GP120 WITH GP41-INTERACTIVE REGION: LAYERED ARCHITECTURE AND BASIS OF CONFORMATIONAL MOBILITY | HIV-1 VIRAL SPIKE, MOLECULAR MOTION, PROTEIN ARCHITECTURE, RECEPTOR- TRIGGERED ENTRY, TYPE 1 FUSION PROTEIN, CELL MEMBRANE, DISULFIDE BOND, GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, VIRAL PROTEIN
2nxy:C (VAL2003) to (ILE2108) HIV-1 GP120 ENVELOPE GLYCOPROTEIN(S334A) COMPLEXED WITH CD4 AND ANTIBODY 17B | HIV, GP120, ANTIBODY, CD4, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
1lo4:L (LEU3) to (LEU111) RETRO-DIELS-ALDERASE CATALYTIC ANTIBODY 9D9 | FAB, CATALYTIC ANTIBODY, RETRO-DEILS-ALDERASE, IMMUNE SYSTEM
4p59:L (ASP1) to (ILE106) HER3 EXTRACELLULAR DOMAIN IN COMPLEX WITH FAB FRAGMENT OF MOR09825 | HER3 RECEPTOR, THERAPEUTIC ANTIBODY, FAB FRAGMENT, ANTI-HER3, SIGNALING PROTEIN, IMMUNE SYSTEM
3a67:L (ILE2) to (ILE106) CRYSTAL STRUCTURE OF HYHEL-10 FV MUTANT LN31D COMPLEXED WITH HEN EGG WHITE LYSOZYME | ANTIGEN-ANTIBODY COMPLEX, MUTANT, IMMUNE SYSTEM-HYDROLASE COMPLEX, ALLERGEN, ANTIMICROBIAL, BACTERIOLYTIC ENZYME, DISULFIDE BOND, GLYCOSIDASE
1n0x:L (ILE2) to (ARG106) CRYSTAL STRUCTURE OF A BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY IN COMPLEX WITH A PEPTIDE MIMOTOPE | ANTIBODY-PEPTIDE COMPLEX, PEPTIDE DIMER, IMMUNE SYSTEM
1n0x:M (GLU1) to (ARG106) CRYSTAL STRUCTURE OF A BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY IN COMPLEX WITH A PEPTIDE MIMOTOPE | ANTIBODY-PEPTIDE COMPLEX, PEPTIDE DIMER, IMMUNE SYSTEM
5dd6:L (ILE2) to (ILE106) CRYSTAL STRUCTURES IN AN ANTI-HIV ANTIBODY LINEAGE FROM IMMUNIZATION OF RHESUS MACAQUES | HIV HIV-1 GP41 MPER ANTIBODY, IMMUNE SYSTEM
5dd6:B (GLN3) to (ILE106) CRYSTAL STRUCTURES IN AN ANTI-HIV ANTIBODY LINEAGE FROM IMMUNIZATION OF RHESUS MACAQUES | HIV HIV-1 GP41 MPER ANTIBODY, IMMUNE SYSTEM
1ynl:L (LEU2) to (LEU106) IDENTIFICATION OF KEY RESIDUES OF THE NC6.8 FAB ANTIBODY FRAGMENT BINDING TO SYNTHETIC SWEETERNERS: CRYSTAL STRUCTURE OF NC6.8 CO- CRYSTALIZED WITH HIGH POTENCY SWEETENER COMPOUND SC45647 | TRIETHYL AMINOMETHANE SULFONYL ACID, SWEETENER COMPOUND, SC45647 AND NC174, IMMUNE SYSTEM
1zls:L (VAL2) to (ILE106) FAB 2G12 + MAN4 | HIV NEUTRALIZING ANTIBODY; ANTI-CARBOHYDRATE; DOMAIN-SWAPPING, IMMUNE SYSTEM
2agj:L (VAL3) to (ILE107) CRYSTAL STRUCTURE OF A GLYCOSYLATED FAB FROM AN IGM CRYOGLOBULIN WITH PROPERTIES OF A NATURAL PROTEOLYTIC ANTIBODY | ANTIBODY, IMMUNOGLOBULIN SUPERFAMILY, CATALYTIC ANTIBODY, IMMUNE SYSTEM
5en2:B (ASP1) to (LEU106) MOLECULAR BASIS FOR ANTIBODY-MEDIATED NEUTRALIZATION OF NEW WORLD HEMORRHAGIC FEVER MAMMARENAVIRUSES | IMMUNOGLOBULIN, GLYCOPROTEIN, VIRUS, COMPLEX, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3naa:L (GLN3) to (ILE106) CRYSTAL STRUCTURE OF FAB15 MUT5 | ANTIBODY, ANTIBODY CANONICAL STRUCTURE, THERMAL STABILITY, NON-X-PRO CIS PEPTIDE BOND, ANTIBODY ENGINEERING, IMMUNE SYSTEM
4rwy:L (VAL3) to (ARG106) CRYSTAL STRUCTURE OF VH1-46 GERMLINE-DERIVED CD4-BINDING SITE-DIRECTED ANTIBODY 8ANC131 IN COMPLEX WITH HIV-1 CLADE B YU2 GP120 | HIV-1 ATTACHMENT PROTEIN, BROADLY NEUTRALIZING ANTIBODY 8ANC131, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
3o6k:L (VAL2) to (ALA114) CRYSTAL STRUCTURE OF ANTI-TAT HIV FAB'11H6H1 | ANTIGEN-BINDING SITE, U-SHAPED GROOVE, IMMUNE SYSTEM, TAT HIV
5gru:L (ASP122) to (ILE227) STRUCTURE OF MONO-SPECIFIC DIABODY | DIABODY, ANTIBODY FRAGMENT, IMMUNE SYSTEM
4u0r:C (ASP1) to (ILE110) PLASMODIUM FALCIPARUM RETICULOCYTE-BINDING PROTEIN HOMOLOGUE 5 (PFRH5) BOUND TO MONOCLONAL ANTIBODY 9AD4 | MALARIA ERYTHROCYTE INVASION ANTIBODY-MEDIATED INHIBITION, IMMUNE SYSTEM
5i18:L (VAL3) to (ILE112) CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV1-69/IGKV4-1 | MONOCLONAL ANTIBODY, IMMUNE SYSTEM
5i1k:L (GLU1) to (ILE107) CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV5-51/IGKV3-20 | MONOCLONAL ANTIBODY, IMMUNE SYSTEM
4f9p:D (ASP137) to (LEU242) CRYSTAL STRUCTURE OF THE HUMAN BTN3A1 ECTODOMAIN IN COMPLEX WITH THE 103.2 SINGLE CHAIN ANTIBODY | B7 SUPERFAMILY, BUTYROPHILIN, CD277, IMMUNE SYSTEM
5js9:F (ASP1) to (VAL106) UNCLEAVED PREFUSION OPTIMIZED GP140 TRIMER WITH AN ENGINEERED 8- RESIDUE HR1 TURN BOUND TO BROADLY NEUTRALIZING ANTIBODIES 8ANC195 AND PGT128 | HIV-1 TRIMER, UFO, SOSIP, VACCINE, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
5jsa:F (ASP1) to (VAL106) UNCLEAVED PREFUSION OPTIMIZED GP140 TRIMER WITH AN ENGINEERED 10- RESIDUE HR1 TURN BOUND TO BROADLY NEUTRALIZING ANTIBODIES 8ANC195 AND PGT128 | HIV-1 TRIMER, UFO, SOSIP, VACCINE, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
5tf1:L (GLU1) to (ILE102) STRUCTURE OF CHIMERIC 02-CC FAB, A VRC01-LIKE GERMLINE ANTIBODY | FAB, GERMLINE, VRC01-LIKE, CD4-BS, HIV-1, CDRH3, IMMUNE SYSTEM